optimizing hematology

advertisement
HUDSON - 1
CURRICULUM VITAE
NAME:
MELISSA MARIA HUDSON
SOCIAL SECURITY NUMBER:
430-17-7614
DATE & PLACE OF BIRTH:
23 March 1957; Bryan, Texas
OFFICE ADDRESS:
Department of Oncology
St. Jude Children's Research Hospital
262 Danny Thomas Place; Mailstop 735
Memphis, TN 38105-3678
(901) 595-3384
HOME ADDRESS:
6475 Robbins Ridge Lane
Memphis, TN 38119
(901) 761-8008
ACADEMIC DEGREES:
B.S.
M.D.
1979
1983
Texas A & M University, College Station, Texas
University of Texas Medical School at Houston
PROFESSIONAL APPOINTMENTS:
1983-86
1986-89
1989-1995
1989-93
1993 to
present
1994-2003
1994-to
present
1995-2002
2002 to
present
2003 to
present
2006 to
Present
2007 to
Present
Updated 12/07/2010
Resident, University of Texas Medical School at Houston Affiliated Hospitals (Hermann Hospital
and M. D. Anderson Hospital and Tumor Institute)
Fellow in Pediatric Hematology-Oncology, Division of Pediatrics, University of Texas, M.D.
Anderson Cancer Center and University of Texas Medical School at Houston
Assistant Member, Department of Hematology-Oncology, St. Jude Children's Research
Hospital, Memphis, TN
Assistant Professor, Department of Pediatrics, College of Medicine, University of
Tennessee, Memphis, TN
Director, After Completion of Therapy Clinic, St. Jude Children's Research Hospital
Memphis, TN
Associate Professor, Department of Pediatrics, College of Medicine, University of
Tennessee, Memphis, TN
Secondary Appointment, Division of Behavioral Medicine, St. Jude Children's Research
Hospital, Memphis, TN
Associate Member, Department of Hematology-Oncology, St. Jude Children's Research
Hospital, Memphis, TN
Member, Department of Hematology-Oncology, St. Jude Children’s Research
Hospital, Memphis, TN
Professor of Pediatrics, University of Tennessee Health Science Center College of Medicine,
Memphis, TN.
Director, Cancer Survivorship Division, Department of Oncology
Endowed Chair in Oncology-Cancer Survivorship
HUDSON - 2
CERTIFICATION:
1988
1990
1996
American Board of Pediatrics
American Board of Pediatrics Sub-Board in Pediatric Hematology-Oncology
American Board of Pediatrics Sub-Board in Pediatric Hematology-Oncology
MEDICAL LICENSURES:
1983
1989
Texas (G5189)
Tennessee (19973)
RESEARCH INTERESTS:
Protocol development and clinical investigations in Hodgkin lymphoma
Late effects of cancer therapy
Health education and promotion in childhood cancer survivors
GRANT SUPPORT:
Active
NCI, 5 U24 CA055727, Childhood Cancer Survivor Study, Co-Investigator (2/01/2005-11/30/2012).
NCI, 5 P3O CA21765, CORE Major Program Leaders, Co-Investigator (06/14/2008-02/28/2013).
NCI, R01 CA127964, Efficacy of a Tobacco Quit Line for Childhood Cancer Survivors, Co-Investigator (01/29/200811/30/2012).
ASCO Career Development Award, Evaluation of Long term Effects of Anthracycline-induced Cardiotoxicity, CoInvestigator (07/01/2008-06/30/2011).
NCI, R01 CA132901, Motor Proficiency and Physical Activity in Adult Survivors of Childhood Cancer, Co-Investigator
(04/01/2009-02/28/2013).
NCI, R01 CA129384, Physical Activity to Modify Sequelae and QOL in Childhood ALL, Co-Investigator (08/01/200906/30/2014)
NINR, R01 NR011322, Evaluation of Cardiovascular Outcomes Among Childhood Cancer Survivors, Principal
Investigator (09/30/2009-7/31/2013).
NCI, RO1 CA136782, Trauma and Growth in Pediatric Cancer, Co-Investigator (03/03/2010-01/31/2013).
NCI, R21 HD061296, Predictors of Adolescent Sperm Banking: Development of a Profiling and Referral Tool, CoInvestigator (07/15/2010–06/30/2012).
NCI, R01 MH085849, Risk for Psychopathology and Neurocognitive Impairment in Leukemia Survivors, CoInvestigator (02/05/2010-12/31/2014).
NCI, R21 CA14142921, Investigating the Needs of Childhood Cancer Survivors: The Unreported Experience, CoInvestigator (01/15/2010-12/31/2011).
NCI, 1 R01 CA132899, Adult Neurobehavioral Late Effects of Pediatric Low Grade Brain Tumors, Co-Investigator,
(12/01/2008-11/30/2013).
NCI, 1 RO1CA 134722, Encouraging Mammography and Preventive Opportunities for Women Exposed to Radiation,
Updated 12/07/2010
HUDSON - 3
Co-Investigator (09/23/2009-03/31/2011).
NICHD, 1 R21 HD059292, Vibration Intervention for Bone Enhancement in Childhood Cancer Survivors, CoInvestigator (03/04/2010-02/29/2012).
NCI, 1RO1 CA140254, Low Dose Tamoxifen in Hodgkin’s Disease Survivors for Breast Cancer Risk Reduction,
Principal Investigator (07/01/2010-05/31/2011).
Inactive
NCI, CHILDREN'S-SEATTLE. Health-Related Outcomes for Hodgkin's Disease Survivors, Co-Investigator
(09/21/2004-06/30/2008)
5 R01CA085406-05. Reduction of ETS Exposure in Pediatric Cancer Patients, Co-Investigator (03/01/200202/28/2009)
HONORS AND AWARDS:
Alpha Lambda Delta (1975-79)
Beta Beta Beta Biologic Honor Society (1975-79)
Howard Gravett Scholarship (1976-79)
Julia Ball Lee Scholarship (1976-78)
Welch Foundation Scholarship (1976-79)
Senior Academic Excellence Scholarship (1978-79)
Phi Kappa Phi Honor Society (1978-79)
Summa Cum Laude, Texas A & M University (1979)
Patricia Ward Scholarship for Women Pursuing Careers in Medicine (1979-83)
Alpha Omega Alpha (1983)
American Medical Women's Association Achievement Citation (1983)
Annual Clinical Training Research Project Competition, M. D. Anderson Hospital and Tumor Institute, 3rd Place (1987)
Dr. Paul Meyer Resident Essay Award (1987)
American Cancer Society Clinical Fellowship and Grant (1987-89)
Memphis Best Doctors (2002-2010)
St. Jude Clinical Care Improvement Award (2004)
Who’s Who of American Women (2005, 2006)
Vineberg Distinguished Lecturer, The Montreal Children’s Hospital, Montreal Quebec, Ontario (2005).
White Dove Distinguished Lecturer, Curtis & Elizabeth Anderson Cancer Institute, Savannah, Georgia (2006).
Leading Health Care Professional of World (2006)
W.W. Sutow Visiting Lecturer, University of Texas M.D. Anderson Cancer Center, Houston, Texas (2007)
America’s Top Oncologists (2007-2010)
Best Doctors in America (2007-2010)
St Jude Children’s Research Hospital Endowed Chair, Oncology-Cancer Survivorship (2008)
Memphis Health Care Heroes, 2008
American Association for Cancer Research Team Science Award, 2009
PROFESSIONAL MEMBERSHIPS:
1983-90
1986 to present
1989 to present
1990 to present
1990 to present
1992 to present
1996 to present
PUBLICATIONS:
Updated 12/07/2010
American Academy of Pediatrics
American Cancer Society
Pediatric Oncology Group/Children’s Oncology Group
American Society of Hematology
American Society of Clinical Oncologists
American Society of Pediatric Hematology/Oncology
International Society of Pediatric Oncology
HUDSON - 4
Original Articles
1.
Hudson MM, Frankel LS, Mullins J, Swanson DA. The diagnostic value of surgical testicular biopsy after
therapy for acute lymphocytic leukemia. J Pediatr 107:50-53, 1985.
2.
Hudson MM, Snyder JS, Jaffe N, Kleinerman ES. In vitro and in vivo effect of Adriamycin (ADR) therapy on
monocyte activation by liposome-encapsulated immunomodulators. Cancer Res 48:5256-5263, 1988.
3.
Hudson MM, Markowitz AB, Gutterman JU, Knowles RD, Synder JS, Kleinerman ES. Recombinant human
interleukin-4 and human monocyte activity in vitro and after intravenous administration. Cancer Res 50:31543158, 1990.
4.
Hudson MM, Dahl GV, Kalwinsky DK, Pui C-H. Methotrexate plus L-asparaginase: an active combination for
children with acute nonlymphocytic leukemia. Cancer 65:2615-2618, 1990.
5.
Hudson MM, Jaffe MR, Jaffe N, Ayala A, Raymond AK, Carrasco H, Wallace S, Murray J, Robertson R.
Pediatric osteosarcoma. Therapeutic strategies, results and prognostic factors derived from a ten year experience.
J Clin Oncol 8:1988-1997, 1990.
6.
Jaffe N, Smith D, Jaffe MR, Hudson M, Carasco H, Wallace S, Raymond AR, Ayala A, Murray J, Robertson R.
Intraarterial cisplatin in the management of stage IIB osteosarcoma in the pediatric and adolescent age group. Clin
Orthop Relat Res 270:15-21, 1991.
7.
Hudson MM, Raimondi SC, Behm FG, Pui C-H. Childhood acute leukemia with the t(11;19)(q23;p13).
Leukemia 5:1064-1068, 1991.
8.
Rao BN, Santana VM, Parham D, Pratt CB, Fleming ID, Hudson MM, Fontanesi J, Phillip P, Schell MJ.
Pediatric nonrhabdomyosarcomas of the extremities. Arch Surg 126:1490-1495, 1991.
9.
Hudson MM, Greenwald C, Thompson E, Wilimas J, Marina N, Fairclough D, Kauffman W, Bozeman P,
Mackert PW, Abromowitch M, Jenkins J, Boulden T, Kun L. Efficacy and toxicity of multiagent (COP/ABVD)
chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease. J Clin
Oncol 11:100-108, 1993.
10. Hudson MM, Pratt C. Risk of delayed second primary neoplasms after treatment of malignant lymphoma. Surg
Oncol Clin N Am 2:319-328, 1993.
11. Hanna SL, Fletcher BD, Boulden TF, Hudson MM, Greenwald CA, Kun LE. STIR MR imaging of
infradiaphragmatic lymphadenopathy in children and adolescents with Hodgkin's disease: Comparison with
lymphography and CT. J Magn Reson Imag 3:461-470, 1993.
12. Hudson MM, Weinstein HJ, Donaldson SS, Greenwald C, Kun L, Tarbell NJ, Humphrey WA, Rupp CR, Marina
NM, Wilimas J, Link MP. Acute hypersensitivity reactions to etoposide in a vinblastine/etoposide/
prednisone/doxorubicin regimen for Hodgkin's disease. J Clin Oncol 11:1080-1084, 1993.
13. Marina NM, Rodman J, Shema SJ, Bowman LC, Douglass E, Furman W, Santana VM, Hudson MM, Wilimas J,
Meyer W, Madden T, Pratt C. Phase I study of escalating targeted doses of carboplatin combined with ifosfamide
and etoposide in children with relapsed solid tumors. J Clin Oncol 11:554-560, 1993.
14. Pui C-H, Hudson M, Luo X, Wilimas J, Crist WM, Evans W. Reappraisal of clinical implication of serum
interleukin-2 receptor levels in children with Hodgkin disease. Leukemia 7:1242-1244, 1993.
15. Pui C-H, Luo X, Evans E, Martin S, Rugg A, Wilimas J, Crist WM, Hudson M. Serum intracellular adhesion
molecule-1 in childhood malignancy. Blood 82:895-898, 1993.
Updated 12/07/2010
HUDSON - 5
16. Marina NM, Shema SJ, Bowman LC, Rodman J, Douglass EC, Furman WL, Pappo A, Santana VM, Hudson M,
Meyer WH, Pratt CB. Failure of granulocyte-macrophage colony-stimulating factor to reduce febrile neutropenia
in children with recurrent solid tumors treated with ifosfamide, carboplatin, and etoposide chemotherapy. Med
Ped Oncol 23:328-334, 1994.
17. Mulhern RK, Tyc VL, Phipps S, Crom D, Barclay D, Greenwald C, Hudson M, Thompson EI. Health-related
behaviors of survivors of childhood cancer. Med Ped Oncol 25:159-165, 1995.
18. Ribeiro RC, Rivera GK, Hudson MM, Kun LK, Mulhern RK, Hancock M, Mahmoud H, Crist WM, Pui C-H.
Outcome of children with acute lymphoblastic leukemia and an isolated central nervous system relapse treated with
an intensive protocol (R-11). J Clin Oncol 13:333-338, 1995.
19. Beaty O, Hudson MM, Greenwald C, Luo X, Fang L, Wilimas JA, Thompson EI, Kun L, Pratt C. Subsequent
malignancies in children and adolescents after treatment for Hodgkin disease. J Clin Oncol 13:603-609, 1995.
20. Marina N, Greenwald C, Fairclough D, Thompson E, Wilimas J, Mackert PW, Hudson M, Stokes D, Bozeman P.
Serial pulmonary function studies in children treated for newly diagnosed Hodgkin's disease with mantle
radiotherapy plus alternating cycles of COP and ABVD. Cancer 75:1706-1711, 1995.
21. Fletcher BD, Kauffman, WM, Kaste SC, Winer-Muram HT, Fang L, Chen G, Hudson M. Use of thallium-201 to
detect pediatric Hodgkin disease. Radiology 196:851-855, 1995.
22. Mathew P, Bowman L, Williams R, Jones D, Rao B, Schropp K, Warren B, Klyce MK, Whitington G, Hudson
M. Complications and effectiveness of gastrostomy feedings in pediatric cancer patients. Am J Ped Hematol
Oncol 18(1):81-85, 1996.
23. Rivera GR, Hudson MM, Liu Q, Benaim E, Ribeiro RC, Crist WM, Pui C-H. Effectiveness of intensified
rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemia.
Blood 88:831-837, 1996.
24. Crom DB, Kaste SC, Tubergen DG, Greenwald CA, Sharp GB, Hudson MM. Ultrasonography for thyroid
screening after head and neck irradiation in childhood cancer survivors. Med Ped Oncol 28:15-21, 1997.
25. Gross E, Rao B, Pappo A, Michalkiewicz E, Hudson MM, Kaste SC, Greenwald CA, Pratt CB. Soft tissue
sarcoma of the hand in children: Clinical outcome and management. J Pediatr Surgery 32:698-702, 1997.
26. Razzouk BI, Gan YJ, Mendonca C, Jenkins JJ, Liu Q, Hudson M, Sixbey J, Ribeiro R. Epstein-Barr virus (EBV)
and pediatric Hodgkin's disease (HD): relationship to age, histiotype and geographic region. Med Pediatr Oncol
28:248-254, 1997.
27. Hudson MM, Jones D, Boyett J, Sharp GB, Pui C-H. Late mortality of long-term survivors of childhood cancer. J
Clin Oncol 15:2205-2213, 1997.
28. Tyc VL, Hudson MM, Hinds P, Elliott V, Kibby MY. Tobacco use among pediatric cancer patients:
recommendations for developing clinical smoking interventions. J Clin Oncol 15: 2194-2204, 1997.
29. Michalkiewicz E, Rao B, Gross E, Luo X, Bowman L, Pappo A, Kaste S, Hudson MM, Greenwald C, Jenkins J,
Pratt C. Complications of pelvic exenteration in children who have genitourinary rhabdomyosarcoma. J Pediatr
Surgery 32:1277-1282, 1997.
30. Hudson MM, Donaldson SS. Hodgkin's disease. Pediatr Clin North Am 44(4): 891-906, 1997.
31. Hudson MM, Tyc VL, Cremer LK, Luo X, Li H, Rao BN, Meyer WK, Crom DB, Pratt CB. Satisfaction after
limb-sparing surgery and amputation for pediatric malignant bone tumors. J Pediatr Oncol Nursing 15(2):60-69,
1998.
Updated 12/07/2010
HUDSON - 6
32. Caver T, Slobod K, Flynn P, Behm. F, Hudson MM, Turner EV, Webster R, Boyett J, Tassie TL, Pui C-H,
Hurwitz J. Profound abnormality of the B/T lymphocyte ratio during chemotherapy for pediatric acute
lymphoblastic leukemia (ALL). Leukemia 12:619-622, 1998.
33. Wilimas J, Hudson MM, Rao B, Luo X, Lott L, Kaste S. Thrombosis as a late complication of central venous
lines used in the treatment of pediatric malignancies. Pediatrics. 101(2):7, 1998.
34. Kaste S, Hudson MM, Jones DJ, Fryrear R, Greenwald CA, Fleming ID, Pratt CB. Breast masses in women
treated for childhood cancer: incidence and screening guidelines. Cancer 82:784-92, 1998.
35. Roskrow M, Suzuki N, Gan Y, Sixbey JW, Ng C, Kimbrough S, Hudson MM, Brenner M, Heslop H, Rooney
CM. EBV-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin
disease. Blood 91(9):2925-2934, 1998.
36. Elkins T, Tyc V, Hudson MM, Crom D. Participation in sports by long-term survivors of childhood cancer. J
Pediatr Oncol 16(1):63-73, 1998.
37. Hudson MM, Lee J, Luo X, Greenwald C, Thompson E, Wilimas J, Kun L, Crist W. Increased mortality after
successful treatment of Hodgkin's disease. J Clin Oncol 16: 3592-3600, 1998.
38. Walter AW, Hancock ML, Pui C-H, Hudson MM, Ochs JS, Rivera GK, Pratt CB, Boyett JM, Kun LK.
Secondary brain tumors in children treated for acute lymphoblastic leukemia at St. Jude Children's Research
Hospital. J Clin Oncol 16:3761-3767, 1998.
39. Hudson MM, Tyc VL, Jayawardene DA, Gattuso J, Quargnenti A, Greenwald C, Crom DB, Mason C,
Srivastava DK, Hinds P. The feasibility of implementing health promotion interventions to improve health-related
quality of life. Int J Cancer: Supplement 12, 138-142, 1999.
40. Crom DB, Hathaway DK, Tolley EA, Mulhern RK, Hudson MM. Health status and quality of life in long-term
adult survivors of pediatric solid tumors. Int J Cancer: Supplement 12, 25-31, 1999.
41. Fletcher BD, Xiong X, Kauffman WM, Kaste SC, Hudson MM. Use of thallium-201 to monitor mediastinal
involvement following treatment of pediatric Hodgkin disease. Radiology 209(2): 471-475, 1998.
42. Tyc V, Hudson MM, Hinds P. Health promotion interventions for adolescent cancer survivors. Cognitive and
Behavioral Practice 6: 128-136, 1999.
43. Hale GA, Marina NM, Jones-Wallace D, Greenwald CA, Jenkins JJ, Rao BN, Luo X, Hudson MM. Late effects
of treatment for germ cell tumors during childhood and adolescence. J Ped Hem Oncol 21 (2): 115-122, 1999.
44. Shah AB, Hudson MM, Poquette C, Luo X, Wilimas J, Kun LE. Long-term follow-up of children and
adolescents treated with primary radiotherapy for supradiaphragmatic Hodgkin's disease at St. Jude Children's
Research Hospital. Int J Rad Onc Biol Phys 44(4) 867-877, 1999.
45. Lustig RH, Rose SR, Burghen GA, Broome DC, Smith K, Li H, Hudson MM, Heideman RL, Kun LE.
Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a
somatostatin agonist. J Peds 135:162-168, 1999.
46. Hudson MM, Donaldson SS. Treatment of pediatric Hodgkin's lymphoma. Semin Hematol 36(3): 313-323,
July, 1999.
47. Kaste SC, Chesney RW, Hudson MM, Lustig RH, Rose SR, Carbone LD. Bone mineral status during and after
therapy of childhood cancer: A growing population with multiple risk factors for impaired bone health. J Bone
Miner Res 14 (12): 2010-2014, 1999.
Updated 12/07/2010
HUDSON - 7
48. Rose SR, Lustig RH, Pitukcheewanont P, Broome DC, Burghen GA, Li H, Hudson MM, Kun LE, Heideman RL.
Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. J Clin Endocrinol Metab 84 (12):
4472-4479, 1999.
49. Feeny D, Furlong W, Mulhern R, Barr, R, Hudson MM. A framework for assessing health-related quality of life
among children with cancer. Int J Cancer: Supplement 12, 2-9, 1999.
50. Sandoval C, Hudson MM, Ozkaynak MF, Tugal O, Jayabose S. Down syndrome and Hodgkin's disease. Med
Pediatr Oncol 34:304-305, 2000.
51. Strickland DK, Riely CA, Patrick CC, Wallace DJ, Boyett JM, Waters B, Fleckenstein JF, Dean PJ, Caver TE,
Hudson, MM. Hepatitis C infection among survivors of childhood cancer. Blood 95 (10):3065-3070, 2000.
52. Leung W, Hudson MM, Harrison P, Boyett J, Zhu Y, Rivera G, Ribeiro R, Sandlund J, Evans W, Kun L, Pui CH. Late effects in survivors of infant leukemia. Leukemia 14:1185-1190, 2000.
53. Leung W, Hudson MM, Strickland D, Phipps S, Srivastava D, Ribeiro R, Rubnitz J, Sandlund J, Kun L, Bowman
L, Razzouk BI, Mathew P, Evans W, Pui C-H. Late effects of treatment in survivors of childhood acute myeloid
leukemia. J Clin Oncol 18: 3273-3279, 2000.
54. Leung W, Ribeiro RC, Hudson MM, Tong X, Srivastava DK, Rubnitz JE, Sandlund JT, Razzouk BI, Evans WE,
Pui C-H. Second malignancy after treatment of childhood acute myeloid leukemia. Leukemia 15: 41-45, 2001.
55. Thompson SJ, Leigh L, Christensen BS, Xiaoping X, Kun LE, Heideman RL, Reddick WE, Gajjar A, Merchant
T, Pui C-H, Hudson MM, Mulhern RK. Immediate neurocognitive effects of methylphenidate on learningimpaired survivors of childhood cancer. J Clin Oncol 19 (6): 1802-1808, 2001.
56. Shenep JL, Flynn PM, Baker DK, Hetherington S, Hudson MM, Hughes WT, Patrick CC, Roberson PK,
Sandlund JT, Santana VM, Sixbey JW, Slobod KS. Randomized comparison of continued intravenous antibiotics
and oral cefixime in the empirical treatment of febrile, neutropenic children with cancer. Clinical Infect Dis 32:2643, 2001.
57. Kaste SC, Jones-Wallace D, Rose SR, Boyett JM, Lustig RH, Rivera GK, Pui C-H, Hudson MM. Bone mineral
decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for
their development. Leukemia 15:728-734, 2001.
58. Tyc VL, Hadley W, Throckmorton-Belzer L, Hudson MM. Pediatric cancer patients and parents who smoke:
counseling guidelines. Primary Care & Cancer 21 (7):9-16, 2001.
59. Strickland DK, Jenkins JJ, Hudson MM. Hepatitis C infection and hepatocellular carcinoma after treatment for
childhood cancer. J Pediatr Hematol Oncol 23 (8): 527-529, 2001.
60. Belgaumi, AF, Hudson, MM. Childhood acute lymphoblastic leukemia presenting with severe hepatic
dysfunction. Med Pediatr Oncol (37): 142-144, 2001.
61. Leung W, Sandlund JT, Hudson MM, Zhou Y, Hancock ML, Zhu Y, Ribeiro RC, Rubnitz JE, Kun LE, Razzouk
B, Evans WE, Pui C-H. Second malignancy after treatment of childhood non-Hodgkin’s lymphoma. Cancer 92
(7): 1959-1966, 2001.
62. Kadan-Lottick NS, Robison LL, Gurney JG, Neglia JP, Yutaka Y, Hayashi R, Hudson M, Greenberg M, Mertens
AC. What do childhood cancer survivors know about their past diagnosis and treatment?: The Childhood Cancer
Survivor Study. JAMA 287 (14)1832-1839, 2002.
Updated 12/07/2010
HUDSON - 8
63. Sandoval C, Venkateswaran L, Billups C, Slim M, Somasundaram J, Hudson MM. Lymphocyte-predominant
Hodgkin disease in children. Journal of Ped Hem-Onc 24 (4): 269-273, 2002.
64. Swilley S, Strickland DK, Davila R, Levstik M, Ribeiro R, Hudson MM. Brief Report. Hepatitis C infection
during treatment for childhood cancer: pitfalls in diagnosis and management. Med Pediatr Oncol 39: 58-59, 2002.
65. Hudson MM, Tyc VL, Srivastava DK, Gattuso J, Quargnenti A, Crom DB, Mason C, Hinds P. Multi-component
behavioral intervention to promote health protective behaviors in childhood cancer survivors: The Protect Study.
Med Pediatr Oncol 3:9 2-11, 2002.
66. Leung W, Rose SR, Zhou Y, Hancock ML, Burstein S, Schriock EA, Lustig R, Danish RK, Evans WE, Hudson
MM, Pui C-H. Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic
leukemia. J Clin Oncol 20: 2959-2964, 2002.
67. Friedmann AM, Hudson MM, Weinstein HJ, Donaldson SS, Tarbell N, Kun L, Link M. Treatment of
unfavorable childhood Hodgkin’s disease with VEPA and low dose involved field radiation. J Clin Oncol 20(14):
3088-3094, 2002.
68. Donaldson SS, Hudson MM, Lamborn K, Link MP, Billet A, Marcus KC, Hurwitz C, Young JA, Tarbell NJ,
Weinstein HJ. VAMP and low-dose involved field radiation for children and adolescents with favorable, earlystage Hodgkin’s disease—results of a prospective clinical trial. J Clin Oncol 20: 3081-3087, 2002.
69. Sandlund JT, Harrison P, Rivera G, Behm FG, Head D, Boyett J, Rubnitz JE, Gajjar A, Raimondi S, Ribeiro R,
Hudson M, Relling M, Evans W, Pui C-H. Persistence of lymphoblasts in bone marrow on day 15 and day 22-25
of remission induction predicts a dismal treatment outcome in children with acute lymphoblastic leukemia. Blood
100: 43-47, 2002.
70. Garrett KM, Hoffer FA, Behm FG, Gow K, Sandlund JT, Hudson MM. Interventional radiology techniques for
the diagnosis of lymphoma or leukemia. Pediatr Radiol 32: 653-662, 2002.
71. Castellino S, Hudson MM. Health issues in survivors of childhood cancer. South Med J 95 (9): 977-984, 2002.
72. Smith RS, Chen Z, Hudson MM, Link MP, Kun L, Weinstein H, Billett A, Marcus KJ, Tarbell NJ, Donaldson SS.
Prognostic factors in children with Hodgkin's disease treated with combined modality therapy. J Clin Oncol 21
(10): 2026-2033, 2003.
73. Howard SC, Razzouk BI, Kaplan SD, Rivera GK, Sandlund JT, Ribeiro RC, Rubnitz JE, Gajjar AJ, Skoch JP, Roy
S, Hudson M, Pui C-H. Urolithiasis in pediatric patients with acute lymphoblastic leukemia. Leukemia 17: 541546, 2003.
74. Nagarajan R, Neglia JP, Clohisy DR, Yasui Y, Greenberg M, Hudson M, Zevon MA, Terzak JM, Ablin A,
Robison LL. Education, employment, insurance and marital status among 694 survivors of pediatric lower
extremity bone tumors: a report from the Childhood Cancer Survivor Study. Cancer 97 (10):2554-2564, 2003.
75. Gow KW, Lensing S, Hill DA, Krasin MJ, McCarville BM, Rai SN, Zacher M, Spunt SL, Strickland DK, Hudson
MM. Thyroid carcinoma presenting in childhood or after treatment of childhood malignancies: an institutional
experience and review of the literature. J Pediatr Surg 38(11): 1574-1580, 2003.
76. Pui C-H, Cheng C, Rivera GK, Leung W, Sandlund JT, Ribeiro RC, Relling MV, Kun LE, Evans WE, Hudson MM.
Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. N Engl J Med 349:640-649,
2003.
77. Hudson MM, Oeffinger K, Mertens A, Hobbie W, Gurney J, Yeazel M, Chen H, Robison L. Health status of longterm childhood cancer survivors: a report from the Childhood Cancer Survivor Study. JAMA 290(11):1583-1592,
Updated 12/07/2010
HUDSON - 9
2003.
78. Kishi S, Griener J, Cheng C, Das S, Cook E, Pei D, Hudson MM, Rubnitz J, Sandlund JT, Pui C-H, Relling MV.
Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia. J Clin Oncol 21(16): 3084-3091, 2003.
79. Pui C-H, Sandlund J, Deqing P, Rivera G, Howard S, Ribeiro R, Rubnitz J, Razzouk B, Hudson MM, Cheng C,
Raimondi S, Behm F, Relling M, Evans W. Results of therapy for acute lymphoblastic leukemia in black and white
children. JAMA 290 (15): 2001-2007, 2003.
80. Yeazel MW, Oeffinger KC, Gurney JG, Mertens AC, Hudson MM, Emmons KM, Chen H, Robison LL. The
cancer screening practices of adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
Cancer 100(3): 631-640, 2004.
81. Hudson MM, Krasin MJ, Kaste SC. PET imaging in pediatric Hodgkin’s disease. Pediatr Radiol 34(3): 190-198,
2004.
82. Krasin M MJ, Hudson MM, Kaste SC. Positron imaging in pediatric radiation oncology: integration in the treatmentplanning process. Pediatr Radiol 34 (3): 214-221, 2004.
83. Kaste SC, Shidler TJ, Tong X, Srivastava DK, Rochester R, Hudson MM, Shearer PD, Hale GA. Bone Mineral
density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation. Bone Marrow Transplant
33(4):435-441, 2004.
84. Yeazel MW, Gurney JG, Oeffinger KC, Mitby PA, Mertens AC, Hudson MM, Robison LL. An examination of the
dental utilization practices of adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
J Public Health Dent 64(1): 50-54, 2004.
85. Castellino SC, Lensing S, Riely C, Rai SC, Davila R, Fleckenstein J, Levstik M, Taylor S, Dean PJ, Kippenbrock S,
Pope J, Carr J, Strickland DK, Hudson MM. The epidemiology of chronic hepatitis c infection in survivors of
childhood cancer – an update of the St. Jude Children’s Research Hospital hepatitis C seropositive cohort. Blood
103(7): 2460-2466, 2004.
86. Oeffinger K, Mertens A, Hudson MM, Gurney J, Casillas, J, Chen H, Whitton J, Yeazel M, Yasui Y, Robison L.
Health care of young adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
Ann Fam Med 2(1), 61-70, 2004.
87. Hudson MM, Mertens AC, Yasui Y, Hobbie W, Chen H, Gurney JG, Yeazel M, Recklitis CJ, Marina N, Robison
L, Oeffinger KC. Health status in adults treated for childhood cancer: a report from the Childhood Cancer
Survivor Study. Am J Onc Rev 3(3), 165-171, 2004.
88. Rose SR, Schreiber RE, Kearney NS, Lustig RH, Danish RK, Burghen GA, Hudson MM. Hypothalamic dysfunction
after chemotherapy. J Pediatr Endocrinol Metab 17(1), 55-66, 2004
89. Zebrack BJ, Eshelman D, Hudson MM, Mertens AC, Cotter KL, Foster BM, Loftis L, Sozio M, Oeffinger KC.
Health care for Childhood Cancer Survivors: insights and perspectives from a Delphi panel of young adult
survivors of childhood cancer. Cancer 100, 843-850, 2004.
90. Hudson MM, Hester A, Sweeney T, Kippenbrock S, Majcina R, Vear S, Wiard S, Kaplan S. A model of care for
childhood cancer survivors that facilitates research. J Pediatr Oncol Nurs 21(3); 170-174, 2004.
91. Merchant TE, Nguyen L, Nguyen D, Wu S, Hudson MM, Kaste DO. Differential attenuation of clavicle growth after
asymmetric mantle irradiation. Int J Rad Onc Biol Phys 59(2); 556-561, 2004.
92. Hudson MM, Constine LS. Risk-adapted therapy for pediatric patients with Hodgkin’s disease, or tiptoeing along the
efficacy-toxicity tightrope. Am Soc Clin Oncol Education Book 645-652, 2004.
Updated 12/07/2010
HUDSON - 10
93. Hudson MM, Fouladi M, Pui C-H. Complications in long-term survivors of childhood cancer. Am Soc Clin Oncol
Education Book 677-681, 2004.
94. Mertens AC, Cotter KL, Foster BM, Zebrack BJ, Hudson MM, Eshelman D, Loftis L, Sozio M, Oeffinger KC.
Improving health care for adult survivors of childhood cancer: recommendations from a Delphi panel of health care
policy experts. Health Policy 69: 169-178, 2004.
95. Pui CH, Sandlund JT, Pei D, Campana D, Rivera GK, Ribeiro RC, Rubnitz JE, Razzouk BI, Howard SC, Hudson
MM, Cheng C, Kun LE, Raimondi SC, Behm FG, Downing JR, Relling MV, Evans WE. Improved outcome for
children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St. Jude Children’s Research
Hospital. Blood 104 (9): 2690-2696, 2004.
96. Oeffinger K, Hudson MM. Long-term complications of childhood and adolescent cancer: foundations for providing
risk-based health care for survivors. CA Cancer J Clin 54:208-236, 2004.
97. Eshelman D, Landier W, Sweeney T, Hester AL, Forte K, Darling J, Hudson MM. Facilitating care for childhood
cancer survivors: integrating Children’s Oncology Group Long-Term Follow-Up Guidelines and Health Links in
clinical practice. J Pediatr Oncol Nurs 21 (5): 271-280, 2004.
98. Hudson MM, Krasin M, Link MP, Donaldson SS, Billups C, Merchant TE, Kun L, Billet AL, Kaste S, Tarbell NJ,
Howard S, Friedmann AM, Hurwitz CA, Young JA, Marcus KJ, Rai S, Cowan T, Weinstein HJ. Risk-adapted
combined modality therapy with VAMP/COP and response-based, involved-filed radiation for unfavorable pediatric
Hodgkin’s disease. J Clin Oncol 22(22):4541-4550, 2004.
99. Landier W, Bhatia S, Eshelman D, Forte K, Sweeney T, Hester A, Darling J, Armstrong D, Blatt J, Constine LS,
Freeman CR, Friedman DL, Green DM, Marina N, Meadows AT, Neglia JP, Oeffinger KC, Robison LL, Ruccione
KS, Sklar CA, Hudson MM, for the Children’s Oncology Group Late Effects Committee and Nursing Discipline.
Development of risk-based guidelines for childhood cancer survivors: The Children’s Oncology Group Long-Term
Follow-Up Guidelines. J Clin Oncol 22 (24): 4979-4990, 2004.
100. Tyc VL, Throckmorton-Belzer L, Lensing S, Hudson MM. Smoking among parents of pediatric cancer patients and
children’s exposure to environmental tobacco smoke. J Child Health Care 8(4): 288-300, 2004.
101. Bollard CM, Aguilar L, Straathof KC, Gahn B, Huis MH, Rousseau A, Sixbey J, Gresik MV, Carrum G, Hudson M,
Dilloo D, Gee A, Brenner MK, Rooney CM, Heslop HE. Cytotoxic T lymphocyte therapy for Epstein-Barr virus+
Hodgkin’s disease. J Exp Med 200(12): 1623-1633, 2004.
102. Chollet CT, Britton L, Neel MD, Hudson MM, Kaste SC. An At-risk Cohort for Ankle Osteonecrosis. Clin Orthop
Related Research 430:149-155, 2005.
103. Kaste SC, Howard S, McCarville EB, Krasin MJ, Kogos PG, Hudson MM.
disease in pediatric Hodgkin’s. Pediatr Radiol 35:141-154, 2005.
18
F-FDG-avid sites mimicking active
104. Rivera G, Zhou Y, Hancock M, Gajjar A, Rubnitz J, Ribeiro R, Sandlund J, Hudson MM, Relling M, Evans W, Pui CH. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia. Cancer
103(2):368-376, 2005.
105. Sunga AY, Ebert MM, Oeffinger KC, Hudson MM, Mahoney MC. Care of cancer survivors. Am Fam Physician
71(4): 699-706, 2005.
106. Rose SR, Danish RK, Kearney NS, Schreiber RE, Lustig RH, Burghen GA, Hudson MM. ACTH deficiency in
childhood cancer survivors. Pediatr Blood Cancer 44:1-6, 2005
Updated 12/07/2010
HUDSON - 11
107. Phipps S, Long A, Hudson M, Rai SN. Symptoms of posttraumatic stress in children with cancer and their parents:
effects of informant and time from diagnosis. Pediatr Blood Cancer 45:952-959, 2005.
108. Cox CL, McLaughlin RA, Rai SN, Steen BD, Hudson MM. Adolescent survivors: a secondary analysis of a clinical
trial of a health promotion intervention. Pediatr Blood Cancer 45:144-154, 2005.
109. Robison L, Green D, Hudson MM, Meadows A, Mertens A, Packer R, Sklar C, Strong L, Yasui Y, Zeltzer L.
Long-term outcomes of adult survivors of childhood cancer: results from the Childhood Cancer Survivor Study.
Cancer 104 (S11): 2557-2654, 2005.
110. Hudson MM. A model for care across the cancer continuum. Cancer 104(S11): 2638-2642, 2005.
111. Crom DB, Hinds PS, Gattuso JS, Tyc V, Hudson, MM. Creating the basis for a breast health program for female
survivors of Hodgkin’s disease using a participatory research approach. Oncology Nurs Forum 32(6):1131-1141,
2005.
112. Spunt SL, Sweeney TA, Hudson MM, Billups CA, Krasin MJ, Hester AL. Late effects of pelvic rhabdomyosarcoma
and its treatment in female survivors. J Clin Oncol 23: 7143-7151, 2005.
113. Castellino SM, Casillas J, Hudson MM, Mertens AC, Whitton J, Brooks SL, Zeltzer LK, Ablin A, Castleberry R,
Hobbie W, Kaste SK, Robison LL. Minority adult survivors of childhood cancer: a comparison of long-term
outcomes, health care utilization and health related behaviors from the Childhood Cancer Survivor Study. J Clin Oncol
23:6499-6507, 2005.
114. Krasin MH, Rai SN, Kun LE, Merchant TE, Metzger ML, Kaste SC, Howard SC, Hudson MM. Patterns of treatment
failure in pediatric and young adult patients with Hodgkin’s disease: local disease control with combined modality
therapy. J Clin Oncol 23(33): 8406-8413, 2005.
115. Hijiya N, Liu W, Sandlund JT, Jeha S, Razzouk BI, Ribeiro RC, Rubnitz JE, Howard SC, Kyzer EP, Redd DS, Cheng
C, Rivera GK, Hudson MM, Relling MV, Pui C-H. Overt testicular disease at diagnosis of childhood acute
lymphoblastic leukemia: lack of therapeutic role of local irradiation. Leukemia 19 (8):1399-1403, 2005.
116. Pui C-H, Pei D, Sandlund JT, Campana D, Ribeiro RC, Razzouk BI, Rubnitz JE, Howard SC, Hijiya N, Jeha S, Cheng
C, Downing JR, Evans WE, Relling MV, Hudson MM. Risk of adverse events after completion of therapy for
childhood acute lymphoblastic leukemia. J Clin Oncol 23:7936-7941, 2005.
117. Ness KK, Mertens AC, Hudson MM, Wall MM, Leisenring WM, Oeffinger KC, Sklar CA, Robison LL, Gurney JG.
Physical performance limitations and participation restrictions among long-term childhood cancer survivors: the
Childhood Cancer Survivor Study. Ann Int Med 143(9): 639-647, 2005.
118. Bowers DC, McNeil DE, Liu Y, Yasui Y, Stovall M, Gurney JG, Hudson MM, Donaldson SS, Packer RJ, Mitby PA,
Kasper CE, Robison LL, Oeffinger KC. Stroke as a late treatment effect of Hodgkin’s disease: a report from the
Childhood Cancer Survivor Study. J Clin Oncol 23:6508-6515, 2005.
119. Metzger ML, Howard SC, Hudson MM, Gow KW, Li C-S, Krasin MJ, Merchant T, Kun L, Shelso J, Pui C-H,
Shochat SJ, McCarville MB. Natural history and management of thyroid nodules in survivors of pediatric Hodgkin
lymphoma. Pediatr Blood Cancer. 46(3): 314-319, 2006.
120. Landier WL, Wallace WHB, Hudson MM. Long-term follow-up of pediatric cancer survivors: education,
surveillance, and screening. Pediatr Blood Cancer 46 (2): 149-158, 2006.
121. Kaste SC, Fleming K, Rai SN, McCammon EA, Tylavsky F, Danish R, Rose SR, Sitter CD, Pui C-H, Hudson MM.
Changes in bone mineral density in survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 46(1):
77-87, 2006.
Updated 12/07/2010
HUDSON - 12
122. Bashir H, Motl S, Metzger M, Howard S, Kaste S, Krasin MP, Hudson MM. Itraconazole-enhanced chemotherapy
toxicity in a patient with Hodgkin lymphoma. J Pediatr Hematol Oncol 28 (1): 33-35, 2006.
123. Metzger ML, Hudson MM, Somes GW, Shorr RI, Li C-S, Krasin MJ, Shelso J, Pui C-H, Howard SC. White race as a
risk factor for hypothyroidism following treatment for pediatric Hodgkin lymphoma. J Clin Oncol 24:1516-1521, 2006.
124. Russell KM, Hudson M, Long A, Phipps S. Assessment of health-related quality of life in children with cancer:
consistency and agreement between parent and child reports. Cancer 106:2267-2274, 2006
125. Cox C, McLaughlin RA, Steen BD, Hudson MM. Predicting and modifying substance abuse in childhood cancer
survivors. Oncology Nursing Forum. 33(1): 51-60, 2006.
126. Hudson MM, Findlay S. Health risk behaviors and health promotion in adolescent and young adult cancer survivors.
Cancer 107(7 Suppl):1695-1701, 2006.
127. Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, Friedman D, Marina N, Hobbie W,
Kadan-Lottick NS, Schwartz CL, Leisenring W, Robison LL. Incidence and severity of chronic health conditions in
adult survivors of pediatric cancer: A report from the Childhood Cancer Survivor Study. N Engl J Med 355(15):15721582, 2006.
128. Hijiya N, Panetta JC, Zhou Y, Kyzer EP, Howard SC, Jeha S, Razzouk BI, Ribeiro RC, Rubnitz JE, Hudson MM,
Sandlund JT, Pui C-H, Relling MV. Body mass index does not influence pharmacokinetics or outcome of treatment in
children with acute lymphoblastic leukemia. Blood 108:3997-4002, 2006.
129. Punyko JA, Gurney JG, Baker KS, Hayashi RJ, Hudson MM, Lui Y, Robison LL, Mertens AC. Physical function and
attainment of life goals in adult survivors of childhood and adolescent rhabdomyosarcoma: a report from the
Childhood Cancer Survivor Study. J Psycho-Oncol 16:26-37, 2006.
130. Bashir H, Crom D, Metzger M, Mulcahey J, Jones D, Hudson MM. Cisplatin-induced hypomagnesemia and cardiac
dysrhythmia. Pediatr Blood Cancer 49: 867-869, 2006
131. Goodwin T, Oosterhuis E, Kiernan M, Hudson MM, Dahl GV. Attitudes and practices of pediatric oncology
providers regarding fertility issues. Pediatr Blood Cancer 48:80-85, 2007.
132. Crom DB, Tyc VL, Rai SN, Deng X, Hudson MM, Booth A, Rodrigues LN, Zhang L, McCammon E, Kaste SC.
Retention of survivors of acute lymphoblastic leukemia in a longitudinal study of bone mineral density. J Child Health
10 (4): 337-350, 2006.
133. Donaldson SS, Link MP, Weinstein HJ, Rai SN, Brain S, Billett AL, Hurwitz CA, Krasin M, Kun LE, Marcus KC,
Tarbell NJ, Young JA, Hudson MM. End results of a prospective clinical trial with VAMP and low-dose involved
field radiation for children with low risk Hodgkin’s disease. J Clin Oncol 25:332-337, 2007.
134. Razzouk BI, Rose SR, Hongeng S, Wallace D, Smeltzer MP, Zacher M, Pui C-H, Hudson MM. Obesity in survivors
of childhood acute lymphoblastic leukemia and lymphoma: a single institution’s experience. J Clin Oncol 25: 11831189, 2007.
135. Hijiya N, Hudson MM, Lensing S, Zacher M, Onciu M, Behm FG, Razzouk BI, Ribeiro RC, Rubnitz JE, Sandlund
JT, Rivera GK, Evans WE, Relling MV, Pui C-H. Cumulative incidence of secondary neoplasms as the first event after
treatment of childhood acute lymphoblastic leukemia increases over 30 years. JAMA 297(11): 1207-1215, 2007.
136. Morris EB, Gajjar A, Okuma J, Yasui Y, Wallace D, Merchant TE, Fouladi M, Broniscer A, Kun L, Robison L,
Hudson MM. Survival and late mortality in long-term survivors of pediatric central nervous system tumors. J Clin
Oncol 25:1532-1538, 2007.
Updated 12/07/2010
HUDSON - 13
137. Hodgson DC, Hudson MM, Constine LS. Pediatric Hodgkin lymphoma: maximizing efficacy, minimizing toxicity.
Semin Radiat Oncol 17:230-242, 2007.
138. Armstrong GT, Sklar CA, Hudson MM, Robison LL. Long-term health status among survivors of childhood cancer:
does gender matter? J Clin Oncol 25:4477-4489, 2007.
139. Hsu SC, Metzger ML, Hudson MM, Pedrosa F, Lins M, Pedrosa M, Barros C, Maciel K, Pui CH, Ribeiro RC,
Howard SC. Comparison of treatment outcomes of childhood Hodgkin lymphoma in two US center and a center in
Recife, Brazil. Pediatr Blood Cancer 49: 139-144, 2007.
140. Bashir H, Hudson MM, Kaste SC, Howard SC, Krasin M, Metzger ML. Pericardial involvement at diagnosis in
pediatric Hodgkin lymphoma. Pediatr Blood Cancer 49: 666-671, 2007.
141. Jurbergs N, Long A, Hudson M, Phipps SS. Self-report of somatic symptoms in survivors of childhood cancer: effects
of adaptive style. Pediatr Blood Cancer 49: 84-89, 2007.
142. Nathan PC, Ness KK, Greenberg ML, Whitton J, Hudson M, Mertens A, Laverdiere C, Wolden S, Davidoff A,
Robison LL, Zeltzer L, Gurney JG. Quality of life in adult survivors of childhood Wilms’ tumor or neuroblastoma: a
report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer 49: 704-15, 2007.
143. Hudson MM, Rai SN, Nunez C, Merchant TE, Marina N, Zalamea N, Cox C, Phipps S, Pompeu R, Rosenthal D.
Non-invasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors. J Clin Oncol 25:36353643, 2007.
144. Anghelescu DL, Burgoyne LL, Liu T, Li C-S, Pui C-H, Furman WL, Hudson MM, Sandlund JT. Clinical and
diagnostic imaging findings predict anesthetic complications in children presenting with malignant mediastinal masses.
Pediatric Anesthesia 17:1090-1098, 2007.
145. Florin TA, Fryer GE, Miyoshi T, Weitzman M, Mertens AC, Hudson MM, Sklar CA, Emmons K, Hinkle A, Whitton
J, Stovall M, Robison LL, Oeffinger KC. Physical inactivity in adult survivors of childhood acute lymphoblastic
leukemia: a report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev 16(7):1356-1363,
2007.
146. Crom DB, Lensing SY, Rai SN, Snider MA, Cash DK, Hudson MM. Marriage, employment, and health insurance in
adult survivors of childhood cancer. J Cancer Surviv 1: 237-245, 2007.
147. Klosky JL, Tyc VL, Garces-Webb D, Buscemi J, Klesges RC, Hudson MM. Emerging issues in smoking among
adolescent and adult caner survivors: a comprehensive review. Cancer 110 (11):2408-2419, 2007.
148. Oosterhuis BE, Goodwin T, Kiernan M, Hudson MM, Dahl GV. Concerns about infertility risks among pediatric
oncology patients and their parents. Pediatr Blood Cancer 48: 80-85, 2007.
149. Nunez SB, Mulrooney DA, Laverdiere C, Hudson MM. Risk-based health monitoring of childhood cancer survivors:
a report from the Children’s Oncology Group. Curr Oncol Rep 9(6): 440-452, 2007.
150. Kaste SC, Ahn H, Liu T, Liu W, Krasin MJ, Hudson MM, Spunt SL. Bone mineral density deficits in pediatric
patients treated for sarcoma. Pediatr Blood Cancer 50:1032-1038, 2008.
151. Shankar SM, Marina N, Hudson M, Hodgson D, Adams MJ, Bhatia S, Meeske K, Chen MH, Kinahan KE, Steinberger
J, Rosenthal D. Pediatrics 121 (2): e387-396, 2008.
152. Nandagopal R, Laverdiere C, Mulrooney D, Hudson MM, Meacham L. MiniReview: endocrine late effects of
childhood cancer therapy. Hormone Research 69:65-74, 2008.
Updated 12/07/2010
HUDSON - 14
153. Kurt BA, Armstrong GT, Cash DK, Krasin MJ, Morris EB, Spunt SL, Robison LL, Hudson MM. Managing the
childhood cancer survivor in the pediatric practice. J Pediatr 152 (4): 458-466, 2008.
154. Tercyak KP, Britto MT, Hanna KM, Hollen PJ, Hudson MM. Prevention of tobacco use among medically at-risk
children and adolescents: clinical and research opportunities in the interest of public health. J Pediatr Psychol 33 (2):
119-132, 2008.
155. Cox CL, Rai S, Rosenthal D, Phipps S, Hudson MM. Subclinical late cardiac toxicity in childhood caner survivors:
impact on quality of life. Cancer 112:1835-1844, 2008.
156. Metzger ML, Hudson MM, Krasin MJ, Kun L, Pui CH, Howard SC. Racial differences in event-free survival for
pediatric Hodgkin lymphoma. J Clin Oncol 26 (8): 1282-1288, 2008.
157. Wasilewski-Masker K, Kaste SC, Hudson MM, Esiashvili N, Mattano LA, Meacham LR. Bone mineral deficits in
survivors of childhood cancer: long-term follow-up guidelines and review of the literature. Pediatrics 121 (3): e705713, 2008.
158. Cox CL, Montgomery M, Rai SN, McLaughlin R, Steen BD, Hudson MM. Supporting breast self-examination in
female childhood cancer survivors: a secondary analysis of a behavioral intervention. Oncol Nurs Forum 35:423-430,
2008.
159. Hudson MM. Survivors of childhood cancer: coming of age. Hematol Oncol Clin North Am 22: 211-231, 2008.
160. Mulrooney DA, Neglia JP, Hudson MM. Caring for adult survivors of childhood cancer. Curr Treatt Options Oncol
9: 51-66, 2008.
161. Sandlund JT, Santana VM, Hudson MM, Onciu M, Behm FG, Head D, Murray DJ, Ribeiro R, Wallace D,
Rencher R, Pui C-H. Combination of dexamethasone, high-dose cytarabine and carboplatin is effective for
advanced large cell non-Hodgkin lymphoma. Cancer 113(4): 782-790, 2008.
162. Constine LS, Tarbell N, Hudson M, Schwartz C, Fisher S, Muhs A, Basu S, Kun L, Ng A, Mauch P, Sandhu A,
Culakova E, Lyman G, Mendenhall N. Subsequent malignancies in children treated for Hodgkin’s disease:
associations with gender and radiation dose. Int J Radiat Oncol Biol Phys 72(1):24-33, 2008.
163. Basu S, Schwartz C, Fisher S, Hudson M, Tarbell N, Muhs A, Marcus K, Mendenhall N, Mauch P, Kun L, Constine
LS. Unilateral and bilateral breast cancer among females surviving pediatric Hodgkin’s disease. Int J Radiat Oncol
Biol Phys 72 (1): 34-40, 2008.
164. Rai SN, Hudson MM, McCammon E, Carbone L, Tylavsky F, Smith K, Surprise H, Shelso J, Pui C-H, Kaste S.
Implementing an intervention to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia:
BONEII, a prospective placebo-controlled double-blind randomize interventional longitudinal study design. Contemp
Clin Trials 29 (5) :711-719, 2008.
165. Nathan PC, Greenberg ML, Ness KK, Hudson MM, Mertens AC, Mahoney MC, Gurney JG, Donaldson SS,
Leisenring WM, Robison LL, Oeffinger KC. Medical care in survivors of childhood cancer: a report from the
Childhood Cancer Survivor Study. J Clin Oncol 26:4401-4409, 2008.
166. Hudson MM, Patte C. Education and health promotion in adolescent and young adult cancer survivors. Pediatr Blood
Cancer 50(5 Suppl):1105-1108, 2008.
167. Hoppe RT, Advani RH, Ambinder RF, Bierman PJ, Bloomfield CD, Blum K, Dabaja B, Djulbegovic B, Forero A,
Gordon LI, Hernandez-Ilizaliturri FJ, Hudson MM, Kaminski MS, Love G, Maloney DG, Mansur D, Mauch PM,
Moore JO, Schilder RJ, Weiss LM, Winter JN, Yahalom J, Zelenetz AD. Hodgkin disease/lymphoma. J Natl Compr
Canc Netw. 6(6):594-622, 2008.
Updated 12/07/2010
HUDSON - 15
168. Das P, Ng A, Constine LS, Hodgson, DC, Mendenhall NP, Morris DE, Yunes MJ, Chauvenet AR, Hudson MM,
Winter JN. ACR Appropriateness Criteria on Hodgkin's lymphoma: favorable prognosis stage I and II. J Am Coll
Radiol. Oct 5(10):1054-1066, 2008.
169. Hines-Thomas M, Kaste SC, Hudson MM, Howard SC, Liu WA, Wu J, Kun LE, Shulkin BL, Krasin MJ, Metzger
ML. Comparison of gallium and PET scans at diagnosis and follow-up of pediatric patients with Hodgkin lymphoma.
Pediatr Blood Cancer 51(2):198-203, 2008.
170. Klosky JL, Cash DK, Buscemi J, Lensing S, Garces-Webb DM, Zhao W, Wiard S, Hudson MM. Factors influencing
long-term follow-up clinic attendance among survivors of childhood cancer. J Cancer Surviv 2(4): 225-32, 2008.
171. Cox CL, Rai SN, Rosenthal D, Phipps S, Hudson MM. Subclinical cardiotoxicity in childhood cancer survivors:
Impact on self-reported health. Am J of Hematology and Oncology 7(11):483-493, 2008.
172. Armstrong GT, Liu Q, Yasui Y, Huang S, Ness KK, Leisenring W, Hudson MM, Donaldson SS, King, AA, Stovall
M, Krull KR, Robison LL, Packer RJ. Long-term outcomes among adult survivors of childhood central nervous system
malignancies in the Childhood Cancer Survivor Study. J Natl Cancer Inst 101(13):946-958, 2009.
173. Asfar T, Klesges RC, Sanford SD, Sherrill-Mittleman D, Robison LL, Hudson MM, Somes G, Boyett JM, Lando H.
Trial design: The St. Jude Children's Research Hospital Cancer Survivors Tobacco Quit Line study. Contemp Clin
Trials. Sep 18 2009.
174. Buchanan N, Leisenring W, Mitby PA, Meadows AT, Robison LL, Hudson MM, Mertens AC. Behaviors associated
with ultraviolet radiation exposure in a cohort of adult survivors of childhood and adolescent cancer: a report from the
Childhood Cancer Survivor Study. Cancer 115(18 Suppl):4374-4384, 2009.
175. Cox CL, Hudson MM, Mertens A, Oeffinger K, Whitton J, Montgomery M, Robison LL. Medical screening
participation in the childhood cancer survivor study. Arch Intern Med 169(5):454-462, 2009.
176. Cox CL, Montgomery M, Oeffinger KC, Leisenring W, Zeltzer L, Whitton JA, Mertens AC, Hudson MM, Robison
LL. Promoting physical activity in childhood cancer survivors: results from the Childhood Cancer Survivor Study.
Cancer 115(3):642-654, 2009.
177. Cox CL, Oeffinger KC, Montgomery M, Hudson MM, Mertens AC, Whitton J, Robison LL. Determinants of
Mammography Screening Participation in Adult Childhood Cancer Survivors: Results From the Childhood Cancer
Survivor Study. Oncol Nurs Forum 36(3):335-344, 2009.
178. Diller L, Chow EJ, Gurney JG, Hudson MM, Kadin-Lottick NS, Kawashima TI, Leisenring WM, Meacham LR,
Mertens AC, Mulrooney DA, Oeffinger KC, Packer RJ, Robison LL, Sklar CA. Chronic disease in the Childhood
Cancer Survivor Study cohort: a review of published findings. J Clin Oncol 27(14):2339-2355, 2009.
179. Hijiya N, Ness KK, Ribeiro RC, Hudson MM. Acute leukemia as a secondary malignancy in children and adolescents:
current findings and issues. Cancer 115(1):23-35, 2009.
180. Hudson MM, Mulrooney DA, Bowers DC, Sklar CA, Green DM, Donaldson SS, Oeffinger KC, Neglia JP, Meadows
AT, Robison LL. High-risk populations identified in Childhood Cancer Survivor Study investigations: implications for
risk-based surveillance. J Clin Oncol 27(14):2405-2414, 2009.
181. Kaste SC, Goodman P, Leisenring W, Stovall M, Hayashi RJ, Yeazel M, Beiraghi S, Hudson MM, Sklar CA, Robison
LL, Baker KS. Impact of radiation and chemotherapy on risk of dental abnormalities: a report from the Childhood
Cancer Survivor Study. Cancer 115(24):5817-5827, 2009.
182. Kaste SC, Metzger ML, Minhas A, Xiong Z, Rai SN, Ness KK, Hudson MM. Pediatric Hodgkin lymphoma survivors
at negligible risk for significant bone mineral density deficits. Pediatr Blood Cancer 52(4):516-521, 2009.
Updated 12/07/2010
HUDSON - 16
183. Kaste SC, Thomas NA, Rai SN, Cheon K, McCammon E, Chesney R, Jones D, Pui, CH, Hudson MM. Asymptomatic
kidney stones in long-term survivors of childhood acute lymphoblastic leukemia. Leukemia 23(1):104-108, 2009.
184. Klosky JL, Gamble HL, Spunt SL, Randolph ME, Green DM, Hudson MM. Human papillomavirus vaccination in
survivors of childhood cancer. Cancer 115(24):5627-5636, 2009.
185. Klosky JL, Randolph ME, Navid F, Gamble HL, Spunt SL, Metzger ML, Daw N, Morris EB, Hudson MM. Sperm
cryopreservation practices among adolescent cancer patients at risk for infertility. Pediatr Hematol Oncol. 26(4):252260, 2009.
186. Nathan PC, Ford JS, Henderson TO, Hudson MM, Emmons KM, Casillas JN, Lown EA, Ness KK, Oeffinger KC.
Health behaviors, medical care, and interventions to promote healthy living in the Childhood Cancer Survivor Study
cohort. J Clin Oncol 27(14):2363-2373, 2009.
187. Ness KK, Hudson MM, Ginsberg JP, Nagarajan R, Kaste SC, Marina N, Whitton J, Robison LL, Gurney JG. Physical
performance limitations in the Childhood Cancer Survivor Study cohort. J Clin Oncol. 27(14):2382-2389, 2009.
188. Ness KK, Leisenring WM, Huang S, Hudson MM, Gurey JG, Whelan K, Hobbie WL, Armstrong GT, Robison LL,
Oeffinger KC. Predictors of inactive lifestyle among adult survivors of childhood cancer: a report from the Childhood
Cancer Survivor Study. Cancer 115(9):1984-1994, 2009.
189. Oeffinger KC, Ford JS, Moskowitz CS, Diller LR, Hudson MM, Chou JF, Smith SM, Mertens AC, Henderson TO,
Friedman DL, Leisenring WM, Robison LL. Breast cancer surveillance practices among women previously treated with
chest radiation for a childhood cancer. JAMA 301(4):404-414, 2009.
190. Sandlund JT, Pui CH, Zhou Y, Behm FG, Onciu M, Razzouk BI, Hijiya N, Campana D, Hudson MM, Ribeiro RC.
Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation:
results of St Jude NHL13 study. Leukemia 23(6):1127-1130, 2009.
191. Shulkin BL, Goodin GS, McCarville MB, Kaste SC, Krasin MJ, Hudson MM, Metzger M. Bone and
[18F]fluorodeoxyglucose positron-emission tomography/computed tomography scanning for the assessment of osseous
involvement in Hodgkin lymphoma in children and young adults. Leuk Lymphoma 50(11):1794-1802, 2009.
192. Bhatia S, Casillas J, Hudson MM, Landier W. Long-term follow-up care for pediatric cancer survivors. Pediatrics
123(3):906-915, 2009.
193. Castellino S, Muir A, Shah A, Shope S, McMullen K, Ruble K, Barber A, Davidoff A, Hudson MM. Hepato-biliary
late effects in survivors of childhood and adolescent cancer: A report from the Children's Oncology Group. Pediatr
Blood Cancer 54(5): 663-9, 2010.
194. Lansdale M, Castellino S, Marina N, Goodman P, Hudson MM, Mertens AC, Smith SM, Leisenring W, Robison LL,
Oeffinger KC. Knowledge of hepatitis C virus screening in long-term pediatric cancer survivors: A report from the
Childhood Cancer Survivor Study. Cancer 116(4):974-82, 2010.
195. Metzger ML, Hudson MM, Krasin MJ, Wu J, Kaste SC, Kun LE, Sandlund JT, Howard SC. Initial response to
salvage therapy determines prognosis in relapsed pediatric Hodgkin lymphoma patients. Cancer 116(18):4376-4384,
2010.
196. Henderson TO, Amsterdam A, Bhatia S, Hudson MM, Meadows AT, Neglia JP, Diller LR, Constine LS, Smith RA,
Mahoney MC, Morris EA, Montgomery LL, Landier W, Smith SM, Robison LL, Oeffinger KC. Systematic review:
surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer: a
report from the Children’s Oncology Group. Ann Intern Med 152(7):444-55, 2010.
197. Nathan PC, Ness KK, Mahoney MC, Li Z, Hudson MM, Ford JS, Landier W, Stovall M, Armstrong GT,
Henderson TO, Robison LL, Oeffinger KC. Screening and surveillance for second malignant neoplasms in adult
Updated 12/07/2010
HUDSON - 17
survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med 153(7):442451, 2010.
198. Kahalley LS, Robinson LA, Tyc VL, Hudson MM, Leisenring W, Stratton K, Zeltzer L, Mertens AC, Robison LL,
Hinds PS. Attentional and executive dysfunction as predictors of smoking within the Childhood Cancer Survivor Study.
Nicotine Tob Res 12(4):344-54, 2010.
199. Hines-Thomas MR, Howard SC, Hudson MM, Krasin MJ, Kaste SC, Shulkin BL, Metzger ML. Utility of bone
marrow biopsy at diagnosis in pediatric Hodgkin lymphoma. Haematologica 95(10):1691-1696, 2010.
200. Krull KR, Huang S, Gurney JG, Klosky JL, Leisenring W, Termuhlen A, Ness KK, Srivastava K, Mertens A, Stovall
M, Robison LL, Hudson MM. Adolescent behavior and adult health status in childhood cancer survivors. J Cancer
Surviv 4(3):210-217, 2010.
201. Klosky JL, Tyc VL, Hum A, Lensing S, Buscemi J, Garces-Webb DM, Hudson MM. Establishing the predictive
validity of intentions to smoke among preadolescents and adolescents surviving cancer. J Clin Oncol 28(3): 431-6,
2010.
202. Smith SM, Ford JS, Rakowski W, Moskowitz CS, Diller L, Hudson MM, Mertens AC, Stanton AL, Henderson
TO, Leisenring WM, Robison LL, Oeffinger KC. Inconsistent mammography perceptions and practices among
women at risk of breast cancer following a pediatric malignancy: a report from the Childhood Cancer Survivor
Study. Cancer Causes Control. 21(10):1585-1595, 2010.
203. Tylavsky FA, Smith K, Surprise H, Garland S, Yan X, McCammon E, Hudson MM, Pui CH, Kaste SC.
Nutritional intake of long-term survivors of childhood acute lymphoblastic leukemia: evidence for bone health
interventional opportunities. Pediatr Blood Cancer 55(7):1362-1369, 2010.
204. Kirchhoff AC, Leisenring W, Krull KR, Ness KK, Friedman DL, Armstrong GT, Stovall M, Park ER, Oeffinger KC,
Hudson MM, Robison LL, Wickizer T. Unemployment among adult survivors of childhood cancer: a report from the
Childhood Cancer Survivors Study. Medical Care 48(11):1015-1025, 2010.
205. Hudson MM. Reproductive outcomes for survivors of childhood cancer. Obstet Gynecol. 116(5):1171-1183,
2010.
206. Sandlund JT, Pui CH, Mahmoud H, Zhou Y, Lowe E, Kaste S, Kun LE, Krasin MJ, Onciu M, Behm FG, Ribeiro RC,
Razzouk BI, Howard SC, Metzger ML, Hale GA, Rencher R, Darnell K, Hudson MM. Efficacy of high-dose
methotrexate, ifosfamide, etoposide, and dexamethasone (MIED) salvage therapy for recurrent or refractory malignant
lymphoma. Ann Oncol Epub July 12, 2010.
207. Kahalley LS, Tyc VL, Wilson SJ, Nelms J, Hudson M M, Wu S, Xiong X, Hinds PS. Adolescent cancer survivors'
smoking intentions are associated with aggression, attention, and smoking history. J Cancer Surviv Epub Oct 5,
2010.
208. Montgomery M, Huang S, Cox CL, et al. Physical therapy and chiropractic use among childhood cancer survivors
with chronic disease: impact on health-related quality of life. J Cancer Surviv Epub Oct 5, 2010.
209. Castellino SM, Geiger AM, Mertens AC, Leisenring WM, Tooze, JA, Goodman, P, Stovall M, Robison LL, Hudson
MM. Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer
Survivor Study. Blood. Epub Oct 29, 2010.
210. Casillas J, Castellino SM, Hudson MM, Mertens AC, Lima ISF, Liu Q, Zeltzer LK, Yasui Y, Robison LL, Oeffinger
KC. Impact of insurance type on survivor-focused and general preventive health care utilization in adult survivors of
childhood cancer: the Childhood Cancer Survivor Study (CCSS).” Cancer Epub Nov 10, 2010.
Updated 12/07/2010
HUDSON - 18
211. Oeffinger KC, Hudson MM, Mertens AC, Smith SM, Mitby PA, Eshelman-Kent DA, Ford JS, Jones JK, Kamani S,
Robison LL. Increasing rates of breast cancer and cardiac surveillance among high risk survivors of childhood
Hodgkin lymphoma following a mailed, one-page survivorship care plan. Pediatr Blood Cancer (in press).
212. Armstrong GT, Conklin HM, Huang S, Srivastava D, Sanford R, Ellison DW, Merchant TE, Hudson MM, Hoehn ME,
Robison LL, Gajjar A, Morris EB. Survival and long-term health and cognitive outcomes after low grade glioma.
Neuro-Oncol (in press, 10/25/2010).
213. Hudson MM, Ness KK, Nolan VG, Armstrong GT, Green DM, Morris EB, Spunt SL, Metzger ML, Krull KR, Klosky
JL, Srivastava DK, Robison LL. Prospective medical assessment of adults surviving childhood cancer: study design,
cohort characteristics, and feasibility of the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer (in press, October
2010).
214. Krull KR, Khan RB, Ness KK, Ledet D, Zhu L, Pui CH, Howard SC, Srivastava DK, Sabin ND, Hudson MM, Morris EB.
Symptoms of Attention-Deficit/Hyperactivity Disorder in Long-Term Survivors of Childhood Leukemia. Pediatr Blood
Cancer (in press).
215. Kahalley, L.S., Conklin, H.M., Tyc, V.L., Wilson, S.J., Hinds, P.S., Wu, S., Xiong, X., & Hudson, M.M. ADHD and
secondary ADHD criteria fail to identify many at-risk survivors of pediatric ALL and brain tumor. Pediatric Blood & Cancer
(in press).
Editorials/Letters
1.
Hudson MM, Pratt CB. Second malignancy tumors following Hodgkin's disease in children. J Clin Oncol 13:2143,
1995 (Letter to Editor).
2.
Hudson MM. Treatment of childhood Hodgkin's disease with chemotherapy alone. Annals of Oncology 8:215216, 1997 (Editorial).
3.
Hudson MM. Pediatric Hodgkin's therapy: Time for a paradigm shift. J Clin Oncol 20(18): 3755-3757, 2003
(Editorial).
4.
Oeffinger KC, Sklar CA, Hudson MM. Thyroid nodules and survivors of Hodgkin’s disease. Am Fam Physician:
68:1016, 2003 (Letter to Editor).
5.
Hudson MM. Achieving cure for early stage pediatric Hodgkin’s disease with minimal morbidity: Are we there yet?
Pediatr Blood & Cancer 46 (2): 122-126, 2005 (Editorial).
6.
Hudson MM. Anthracycline cardiotoxicity in long-term survivors of childhood cancer: the light is not at the end of
the tunnel. Pediatric Blood & Cancer 48:649-650, 2007 (Highlight).
7.
Robison LL, Hudson MM. Medical surveillance of long-term survivors of childhood cancer. Eur J Cancer 43(18):
2629-263, 2007 (Editorial).
8.
Hudson MM, Landier W, Bhatia S, Constine LS. Risk-based screening for hypogonadism in childhood cancer
survivors. J Clin Endocrinol Metab. Electronic letter, December 16, 2009.
9.
Metzger ML, Hudson MM. Balancing efficacy and safety in the treatment of adolescents with Hodgkin's lymphoma. J
Clin Oncol. 27(36):6071-6073, 2009 (Editorial).
10. Hudson MM. Pediatric cancer survivorship: is our work nearly done or just beginning. Pediatric Health 4(1):5-7, 2010
(Editorial).
Updated 12/07/2010
HUDSON - 19
11. Sandlund JT, Hudson MM. Hematology: Treatment strategies for pediatric Hodgkin lymphoma. Nat Rev Clin Oncol
7(5):243-4, 2010.
Book Chapters
1.
Kleinerman ES, Hudson MM. Liposome Therapy: A Novel Approach to the Treatment of Childhood
Osteosarcoma. In, Lopez-Berestein G, Fidler TJ (eds), Liposomes in the Therapy of Infectious Diseases and Cancer,
Vol. 89 (UCLA Symposia on Molecular and Cellular Biology), Alan R. Liss, New York, pp. 71-80, 1989.
2.
Hudson MM, Black CT, Halpern J. Rhabdomyosarcoma. In, Gottlieb RA, Pinkel D (eds), Handbook of Pediatric
Oncology. Little, Brown and Company, Boston, Toronto, London. pp. 26, 1989.
3.
Hudson MM. Gastrointestinal Complications: Nausea and Vomiting. In, Gottlieb RA, Pinkel D (eds), Handbook of
Pediatric Oncology. Little, Brown and Company, Boston, Toronto, London. pp. 129, 1989.
4.
Hudson MM. Hodgkin Disease. In: Nelson Textbook of Pediatrics, 15th Edition. Behrman RE, Kliegman RM,
Arvin A (eds). W.B. Saunders Co., Philadelphia, pp. 1457-1459, 1995.
5.
Hudson MM, Donaldson SS. Hodgkin's Disease. In: Pizzo PA, Poplack DG (eds.) Third Edition of Principles and
Practice of Pediatric Oncology. J.B. Lippincott Co., Philadelphia, pp. 523-543, 1995.
6.
Hudson MM, Donaldson SS. Hodgkin's Disease. In: Pediatric Clinics of North America, Link MP (ed). W.B.
Saunders Company, Philadelphia, pp. 891-906, 1996.
7.
Hudson MM, Pui C-H. Late Complications After Leukemia Therapy. In: Childhood Leukemias. Pui C-H (ed).
Cambridge University Press, New York, pp. 463-481, 1999.
8.
Donaldson SS, Hudson MM, Oberlin O, Schellong G. Pediatric Hodgkin's Disease. In: Hodgkin's Disease.
Mauch P, (ed). Lippincott-Raven Publishers, Philadelphia, pp. 531-562, 1999.
9.
Hudson, MM. Long-Term Follow-Up After Childhood Cancer. In: Childhood Cancer: A Handbook from St. Jude
Children's Research Hospital. Perseus Publishing, Cambridge, MA, pp. 505-515, 2000.
10.
Hudson, MM. Late Effects of Cancer Therapy. In: Childhood Cancer: A Handbook from St. Jude Children's
Research Hospital. Perseus Publishing, Cambridge, MA, pp. 491-503, 2000.
11.
Hudson, MM. Hodgkin's Disease. In: Childhood Cancer: A Handbook from St. Jude Children's Research Hospital.
Perseus Publishing, Cambridge, MA, pp. 337-344, 2000.
12.
Hudson MM, Donaldson SS. Hodgkin's Disease. In: Pizzo PA, Poplack DG (eds) Fourth Edition of Principles and
Practice of Pediatric Oncology. Lippincott Williams & Wilkins, Philadelphia. pp 637-660, 2002.
13.
Constine LS, Hudson MM, Asselin BL. Lymphomas in Children. In: Perez C, Brady L, Halperin E, SchmidtUllrich R (eds.) Principles and Practice of Radiation Oncology, Fourth Edition. Lippincott, Williams & Wilkins,
Baltimore, MD, pp. 2285-2307, 2003.
14.
Hudson MM. Healthy Lifestyle and Prevention Strategies. In: Wallace H, Green D (eds) Late Effects of Childhood
Cancer. Edward Arnold Publishers, Ltd. London, England, pp. 366-375, 2004.
15.
Hudson MM. Hepatic Complications. In: Wallace H, Green D (eds.) Late Effects of Childhood Cancer. Edward
Arnold Publishers, Ltd. London, England, pp. 170-175, 2004.
16.
Hudson MM, Constine LS. Risk-Adapted Therapy for Pediatric Patients With Hodgkin’s Disease, or Tiptoeing Along
The Efficacy-Toxicity Tightrope. American Society of Clinical Oncology 2004 Educational Book, 40th Annual Meeting
June 5-8, 2004, New Orleans, LA, 645-652.
Updated 12/07/2010
HUDSON - 20
17.
Asselin B, Hudson M, Mandell L, Constine LS. Pediatric Leukemias and Lymphomas. In: Leibel S, Phillips T
(eds) Textbook of Radiation Oncology, Second Edition. W.B. Saunders Co., Orlando, FL, pp. 1215-1249, 2004.
18.
Hudson MM, Constine LS. Hodgkin’s Disease. In: Halperin, EC, Constine LS, Tarbell NJ, Kun (eds.). Pediatric
Radiation Oncology, 4th Ed. Lippincott Williams and Wilkins, Philadelphia, PA, pp. 223-259, 2005.
19.
Hudson, MM. Late Gastrointestinal and Hepatic Effects. In: Schwartz C, Hobbie W, Constine L, Ruccione K
(eds) Survivors of Childhood Cancer, 2nd Edition. Springer-Verlag, Heidelberg, Germany, pp. 181-202, 2005.
20.
Howard SC, Metzger ML, Hudson MM. Linfoma de Hodgkin. In: Sierrasesumaga L, Antillon Klussman, F,
Bernaola E, Patino A, San Julian M (eds.). Tratado de Oncologia Pediatrica Enfermedades Malignas del Nina y del
Adolescente, Pearson Prentice Hall, Madrid, Spain, pp. 365-415, 2005.
21.
Hudson MM. Late Complications After Leukemia Therapy. In: Childhood Leukemias, Second Edition. Pui C-H
(ed). Cambridge University Press, New York, pp. 750-773, 2006.
22.
Hudson MM, Onciu M, Donaldson SS. Hodgkin Lymphoma. In: Pizzo PA, Poplack DG (eds.) Fifth Edition of
Principles and Practice of Pediatric Oncology. Lippincott Williams & Wilkins, Philadelphia, PA. pp 695-721,
2006.
23.
Hudson MM, Constine LS. Pediatric Hodgkin Lymphoma. In: Clinical Radiation Oncology. Edition 2.
Gunderson LL, Tepper JE (ed). Elsevier, Philadelphia, PA, pp. 1657-1668, 2007.
24.
Hudson MM, Schwartz C, Constine LS. Treatment of Pediatric Hodgkin Lymphoma. In: Pediatric Lymphomas
Weinstein HJ, Hudson MM, Link MP, (eds). Springer-Verlag, Heidelberg, pp. 35-66, 2007.
25.
Hudson MM, Oeffinger KC. Future Health of Survivors and Adolescents and Young Adult Cancer. In: Cancer in
Adolescents and Young Adults. Bleyer A, Barr R (ed). Springer Verlag, Heidelberg, Germany, pp. 451-467, 2007.
26.
Hudson MM, Korholz D, Donaldson SS. Pediatric Hodgkin's Disease. In: Hodgkin Lymphoma. Hoppe RT, Mauch
PM, Armitage JO, Diehl V, Weiss LM (eds). Lippincott Williams & Wilkins, Philadelphia, pp. 293-317, 2007.
27.
Hudson MM, Landier W, Bhatia S, Oeffinger KC, Sklar CA, Meadows A, Horowitz M, Poplack D, Fordis M,
Constine LS. Radiation (and medical) biosurveillance: screening survivors for late effects of therapy using the
Children’s Oncology Group Long-Term Follow-Up Guidelines. In: CURED I – LENT: Late Effects of Cancer
Treatment on Normal Tissues. Rubin P, Constine LS, Marks LB, Okunieff P (eds). Medical Radiology – Radiation
Oncology. Springer Verlag, Heidelberg, Germany, pp.1-9, 2007.
28.
Hudson MM, Asselin BL, Constine LS. Lymphomas in Children. In: Perez and Brady’s Principles and Practice of
Radiation Oncology, Fifth Edition. Halperin EC, Perez CA, Brady LW (eds). Lippincott Williams & Wilkins,
Philadelphia PA, pp.1892-1912, 2008.
29.
Landier W, Earle CC, Bhatia S, Hudson MM, Oeffinger K, Ganz PA, Constine LS. Cancer Survivorship: Our
Challenge, Our Obligation. In: Cancer: Principles and Practice of Oncology, Eighth Edition. DeVita VT, Lawrence
TS, Rosenberg SA (eds). Lippincott Williams & Wilkins, Baltimore, MD, pp. 2743-2756, 2008.
30.
Sunga A, Eberl MM, Oeffinger KC, Hudson MM, Mahoney MC. Care of Cancer Survivors. FP Essentials™,
Edition No. 352, AAFP Home Study, Leawood, KS: American Academy of Family Physicians, September 2008
31.
Oeffinger KC, Hudson MM, Landier W. Survivorship: childhood cancer survivors. In: Primary Care: Clinics in
Office Practice. Wender R, Snyderman D (eds). Elsevier-Saunders, Philadelphia, PA 36(4):743-780, 2009.
32.
Hobbie WL, Hudson MM, Rowland JH, Schwartz LA. Pediatric cancer survivors: moving beyond cure. In: Quick
Reference for Pediatric Oncology Clinicians: The Psychiatric and Psychological Dimensions of Pediatric Cancer
Updated 12/07/2010
HUDSON - 21
Symptom Management. Wiener LS, Pao M, Kazak AE, Kupst MJ, Patenaude AF (eds). Charlottesville, VA, IPOS
Press, 2009
33.
Metzger, M, Krasin M, Metzger M, Onciu M, Hudson MM. Hodgkin Lymphoma. In: Pizzo PA, Poplack DG (eds.)
Sixth Edition of Principles and Practice of Pediatric Oncology. Lippincott Williams & Wilkins, Philadelphia, PA.
pp 638-662, 2010.
34.
Ng A, Hudson MM. Biosurveillance and longitudinal lifelong guidelines. In: ALERT: Adverse Late Effects of
Cancer Treatment. Rubin P, Constine LS, Marks LB, Williams J (eds). Medical Radiology – Radiation Oncology.
Springer Verlag, Heidelberg, Germany (in press, 2008).
35.
Hudson MM, Trippett T. Hodgkin lymphoma. In: Rudolph’s Pediatrics, 22nd Edition. Rudolph AM, Lister G,
Gershon AA, First L, Rudolph C (eds). McGraw-Hill, New York, NY (in press, 2009).
36.
Hodgson DC, Hudson MM, Constine LS. Pediatric Hodgkin lymphoma : the rationale for radiation therapy. In:
Radiotherapy for Hodgkin Lymphoma. Specht L, Yahalom J (eds). Springer Verlag, Heidelberg, Germany (in press,
2009).
37.
Terezakis S, Hudson MM, Constine LS. Hodgkin’s Disease. In: Halperin, EC, Constine LS, Kun LE, Tarbell NJ
(eds.). Pediatric Radiation Oncology, 5th Ed. Lippincott Williams and Wilkins, Philadelphia, PA, (in press, April
2010).
38.
Roberts KB, Hudson MM, Constine LS. Pediatric Hodgkin Lymphoma. In: Clinical Radiation Oncology. Edition
3. Gunderson LL, Tepper JE (ed). Elsevier, Philadelphia, PA, (in press, February 2010).
39.
Hudson MM. Late Complications After Leukemia Therapy. In: Childhood Leukemias, Third Edition. Pui C-H
(ed). Cambridge University Press, New York (in press, May 2010).
40.
Landier W, Earle CC, Bhatia S, Hudson MM, Oeffinger K, Ganz PA, Constine LS. Cancer Survivorship: Our
Challenge, Our Obligation. In: Cancer: Principles and Practice of Oncology, Ninth Edition. DeVita VT, Lawrence
TS, Rosenberg SA (eds). Lippincott Williams & Wilkins, Baltimore, MD, (in press, May 2010).
PROFESSIONAL PRESENTATIONS:
Signal Transduction Workshop, “IL-4 and Human Monocyte Activation In Vitro”, Memphis, TN, September 1989.
Methodist Medical Center of Illinois, "Hodgkin's Disease in Children", Peoria, IL, October 1991.
St. Jude Children's Research Hospital 30th Annual Clinical Symposium, "Hodgkin's Disease: A Solved Problem?" Memphis,
TN, 1991.
St. Jude Children's Research Hospital 26th Annual Clinical Symposium, "Pediatric Hodgkin's Disease" Memphis, TN,
February 1992.
St. Jude Children's Research Hospital Hematology/Oncology Grand Rounds, "Hodgkin's Disease in Children". Memphis,
TN, February 1992.
Grand Rounds, National Institute of Cancer, "Therapy of Pediatric Hodgkin's Disease", Rio de Janeiro, Brazil, February
1993.
LeBonheur Children's Medical Center Pediatric Surgical Grand Rounds, "Update on Pediatric Lymphomas", Memphis, TN,
February 1994.
Maine Medical Center Pediatric Grand Rounds, "Late Effects of Childhood Cancer Therapy", Portland, ME, August 1994.
Updated 12/07/2010
HUDSON - 22
St. Jude Children’s Research Hospital Pediatric Oncology Seminar for Radiologists, “Late Effects of Childhood Cancer
Therapy”, Memphis, TN, September 1994.
LeBonheur Children's Medical Center Pediatric Grand Rounds, "Late Effects After Childhood Cancer”, Memphis, TN,
November 1995.
University of Tennessee, College of Medicine & T.C. Thompson Children's Hospital Pediatric Grand Rounds, "Late Effects
of Cancer Therapy", Chattanooga, TN, October 1995
Congresso Brasilerio De Oncologia Pediatrica, "Biology and Therapy of Pediatric Hodgkin's Disease" and "Late Effects
After Childhood Cancer", Fortaleza, Brazil, September 1996.
Baton Rouge Oncology Journal Club, "Early Death After Successful Treatment of Pediatric Hodgkin's Disease", Baton
Rouge, LA, September 1997.
Pediatric Oncology Group Meeting CRA Continuing Education Session, "Looking Closer at Late Effects", Chicago, IL,
October 1997.
LeBonheur Children's Medical Center Pediatric Grand Rounds, "Increased Mortality After Successful Treatment of
Pediatric Hodgkin's Disease", Memphis, TN, 1998.
Joint Annual Meeting of the International Society of Paediatric Oncology and the American Society of Pediatric
Hematology/Oncology, "Interventions to Reduce Morbidity and Mortality after Childhood Cancer", Montreal, Canada,
September 1999.
VI Venezuelan Hematology, V Ibero-American and I Inter-American Hematology Congress, "Treatment of Pediatric
Hodgkin's Lymphoma", Caracas, Venezuela, October 1999.
VI Venezuelan Hematology, V Ibero-American and I Inter-American Hematology Congress, "Late Complications After
Leukemia Therapy", Caracas, Venezuela, October 1999.
National Conference of Pediatric Hematology Oncology, Sir Ganga Ram Hospital, "Hodgkin's Lymphoma", 3rd, New
Delhi, India, November 1999.
3rd National Conference of Pediatric Hematology Oncology, Sir Ganga Ram Hospital, "Late Effects of Childhood
Cancers", New Delhi, India, November 1999.
XXIV Congresso Brasileiro de Hematologia e Hemoterapia , "Progress in Therapy and Biology of Hodgkin's
Lymphoma" and "Late Effects of Treatment of Pediatric Hematologic Malignancies", Rio de Janeiro, Brasil, May 2000.
UICC Cancer Control Assessment Conference: Did the Year 2000 Measure Up?, “Long-Term Side Effects of
Hematologic Malignancies", Seattle, WA, September 2000.
Tumor Registrars Association of Tennessee Annual Meeting, "Second Malignancies After Childhood Cancer",
Memphis, TN, October 2000.
International Congress on Pediatric Hematology/Oncology , "Treatment of Pediatric Hodgkin's Lymphoma", Shanghai
Children's Medical Center, October 2000.
American Academy of Orthotists and Prosthetists Annual Meeting and Scientific Symposium, “Psychosocial Adaptation
Following Surgery for Pediatric Bone Tumors", Dallas, TX, March 2001.
The University of Texas, MD Anderson Cancer Center Pediatric Grand Rounds, “Sequelae After Childhood Cancer”,
Houston, TX, March 2001.
Updated 12/07/2010
HUDSON - 23
Society for Pediatric Pathology Annual Meeting, “Therapy-Induced Malignancies: The Hodgkin’s Paradigm”, Memphis,
TN, September 2001.
Memorial Sloan Kettering Grand Rounds, "Changing Cancer Therapy: The Hodgkin's Paradigm", February 2002.
National Cancer Registrars Association Annual Meeting, “Pediatric Oncology: The Role of Cancer Registries in
Reducing Cancer-Related Morbidity and Mortality”, May 21-24, 2002.
Cancer Survivorship: Resilience Across the Lifespan, National Cancer Institute, "A Model of Care Across the Cancer
Continuum", Bethesda, MD, June 2-4, 2002.
University of Tennessee College of Medicine Approaching Hepatitis C in 2002, "Hepatitis C Infection After Childhood
Cancer", Memphis, TN, June 8, 2002.
University of Tennessee, College of Medicine Hepatitis C, Seminar "Hepatitis C in Childhood Cancer Survivors.
Memphis, TN, March 3, 2003
Children's Oncology Group Meeting, “Screening Recommendations for High-Risk Populations", Atlanta, GA, March
28, 2003.
Children's Oncology Group Meeting. "The St. Jude After Completion of Therapy Program", Atlanta, GA, March 28,
2003.
American Society of Clinical Oncology Annual Meeting, Pediatric-Oncology I: Leukemia/Lymphoma and Late Effects
Discussion, "Perspectives in Cardiovascular Disease After Childhood Cancer”, Chicago, IL, June 1, 2003.
American Society of Clinical Oncology Annual Meeting, Meet the Professor: Expert Opinion: "Pediatric Hodgkin’s
Disease", Chicago. IL, June 1, 2003.
Maine Children's Cancer Program: Living Healthy After Cancer Survivor Conference, "Learning From Childhood
Survivors", Portland, ME, June 21, 2003.
AICR/WCRF International Research Conference on Food, Nutrition, and Cancer, "Health Status of Adults Who Are
Long-Term Childhood Cancer Survivors: A Report from the CCSS”, Washington D.C., July 17-18, 2003.
NIH/National Institute of Nursing Research Conference, Moving the Research Agenda Forward for Children with
Cancer: The Long View Surviving Childhood Cancer, "A Model for Monitoring Late Effects After Childhood Cancer”,
Bethesda, MD, August 5-6, 2003.
III Encontro Nacional de Grupos Cooperativos, Sociedada Brasileira de Oncologia Pediatrica, "Recent Updates in
Hodgkin's Disease" and "Rescue Therapy for Relapsed Hodgkin's Disease", Sao Paulo, Brasil, August 21-23, 2003.
New Approaches to the Diagnosis and Treatment of Pediatric Cancer. “Sequelae After Childhood Cancer” and
“Treatment of Relapsed Hodgkin’s Disease”, St. Petersburg, Russia, September 9, 2003 and Moscow, Russia,
September 11, 2003.
Taking on Life after Cancer, “Surviving Childhood Cancer”, Birmingham, AL, October 4, 2003.
Multidisciplinary Symposium on Childhood Cancer: Adolescent and Young Adult Oncology: Walking Two Worlds,
“Health Risk Behaviors & Health Promotion in Adolescents and Young Adults”. Toronto, Ontario, November 21-22,
2003.
Baton Rouge Oncology Group, “Delayed Effects After Childhood Cancer Therapy: The Cost of Cure”? Baton Rouge,
LA, February 3, 2004.
American Society of Pediatric Hematology-Oncology 17th Annual Meeting, Satellite Symposium on Advances in the
Updated 12/07/2010
HUDSON - 24
Treatment of Children with Leukemia & Lymphoma, “Risk-Adapted Therapy for Pediatric Hodgkin’s Disease”, San
Francisco, April 30, 2004
Late Effects of Normal Tissues (LENT) V Workshop, “Development of the Children’s Oncology Group Long-Term
Follow-Up Screening Guidelines: Translating Knowledge About Late Effects Into Clinical Practice”, Rochester, NY.
May 19-21, 2004.
Topics in Pediatrics. Cardiac Late Effects after Treatment for Childhood Cancer. Memphis, TN, September 24-25,
2004.
Sixth International Symposium on Hodgkin’s Lymphoma. Participant, Workshop on Adolescent Hodgkin’s Lymphoma,
September 19, 2004.
Primer Congresso Internacional de Cancer del Nino y del Adulto. “Controversies in Hodgkin Lymphoma” and
“Physical and Psychological Consequences of Childhood Cancer Treatment”, Santiago, Chile, October 21-23, 2004.
IX Congresso Brasileiro de Oncologia Pediatrica. “ Quality of Life in Pediatric Oncology:”, “The Young Adult Cured
of Cancer”, “Promoting Quality of Life After Completion of Therapy”, “Optimization of the Treatment of Hodgkin
Disease” and “Late Effects of Treatment of Childhood Cancer”, Sao Paolo, Brazil, November 16-19, 2004.
The University of Oklahoma Health Sciences Center, Grand Rounds, “Providing Care for Childhood Cancer Survivors:
Advice for the Primary Care Provider”, Oklahoma City, Oklahoma, February 23, 2005.
The Leukemia & Lymphoma Society Patient Education Program on Children Coping with Cancer: Back to School and
Beyond. Key Note: “Neurocognitive and Psychosocial Effects of Childhood Cancer,” Memphis, Tennessee, April 8,
2005.
Beyond the Cure, an Educational Conference for Childhood Cancer Survivors. Key Note: “Staying Healthy After
Childhood Cancer,” St. Louis, Missouri, April 23, 2005.
St. Jude Domestic Affiliate Program Annual RN/CRA Conference. “Risk-Adapted Treatment of Pediatric Hodgkin’s
Lymphoma,” Memphis, Tennessee, August 13, 2005.
University of Tennessee Cancer Institute. Hematology-Oncology Fellows Rounds. “Late Effects of the Treatment of
Cancer in Childhood and Adolescence,” Memphis, Tennessee, September 20, 2005.
St. Jude Leukemia/Lymphoma Hematology & Hematopoietic Stem Cell Transplantation Conference. “Risk-Based
Health Care After Childhood Cancer: How To Optimize The Paradigm of Maximal Cure with Minimal Morbidity,”
Memphis, Tennessee, October 4, 2005.
The Montreal Children’s Hospital, Vineberg Lecture Pediatric Medical Grand Rounds. “Risk-Based Health Care After
Childhood Cancer: How to Optimize the Paradigm of Maximal Cure with Minimal Morbidity,” Montreal Quebec,
Ontario, November 2, 2005.
American Society of Hematology 47th Annual Meeting, Meet the Expert, “Risk-Adapted Therapy for Pediatric Hodgkin
Lymphoma”, Atlanta, Georgia, December 11, 2005.
White Dove Distinguished Lecturer, Curtis & Elizabeth Anderson Cancer Institute, “Risk-Based Health Care After
Childhood Cancer.,” Savannah, Georgia, January 20, 2006.
Pediatric Grand Rounds, Stanford University Medical Center, Lucile Salter Packard Hospital. “Fertility and Pregnancy
Outcomes After Childhood Cancer,” Palo Alto, California, February 17, 2006.
St. Jude Grand Rounds. “The Children’s Oncology Group Long-Term Follow-Up Guidelines for Childhood,
Adolescent, and Young Adult Cancers: Translating Knowledge about Late Effects into Clinical Practice,” Memphis,
Tennessee, April 6, 2006.
Updated 12/07/2010
HUDSON - 25
The First Regional Meeting of the Lebanese Society of Hematology and Blood Transfusion. “Hodgkin Lymphoma in
Children and Adolescents and Long-Term Side Effects of Cancer Therapy,” Beirut, Lebanon, April 28, 2006.
Cancer Survivorship Research and Education Conference. “The Children’s Oncology Group Long-Term Follow-Up
Screening Guidelines: Facilitating Risk-Based Care of Childhood Cancer Survivors,” University of Rochester James P.
Wilmont Cancer Center. Rochester, New York, May 19, 2006.
Faculty, Survivorship: Education for Quality Cancer Care, “Survivorship Clinics”, Pasadena, California, July 13-15,
2006.
Meet the Professor, American Society of Clinical Oncology Annual Meeting, “Developing Cancer Survivorship
Programs: Lessons from Successful Initiatives, Atlanta, Georgia, June 3 & 5, 2006.
Keynote speaker, Beyond the Cure Educational Conference, Inova Fairfax Hospital for Children, “Staying Healthy After
Childhood Cancer”, Falls Church, Virginia, July 29, 2006.
Children’s Hospital of Wisconsin, Lance Armstrong Speaker Series, “Staying Healthy After Childhood Cancer”,
Milwaukee, Wisconsin, August 8, 2006
American Society of Clinical Oncology People Living With Cancer Q&A Forum: Cancer Survivorship: Living Beyond
Cancer, August 2006.
St. Jude Children’s Research Hospital Grand Rounds, Cancer and Fertility, Memphis, Tennessee, September 7, 2006.
Psychosocial and Neurocognitive Consequences of Childhood Cancer: A Symposium in Tribute to Raymond K.
Mulhern, “Achieving Social Competence After Childhood Cancer”, Memphis, Tennessee, September 13-15, 2006.
Alex Koufos Memorial Lecture, Akron Children’s Hospital, Progress in Therapy for Pediatric Hodgkin Lymphoma,
Akron, Ohio, September 29, 2006.
Beyond the Cure Educational Conference, Akron Children’s Hospital, Staying Healthy After Childhood Cancer” and
“Neurocognitive and Psychosocial Effects of Cancer Therapy”, Akron, Ohio, September 30, 2006.
President’s Cancer Panel, Promoting Healthy Lifestyles to Reduce the Risk of Cancer, “Impact of Cigarette Smoking on
Health Status of Children and Adolescents with Chronic Disease”, Lexington, Kentucky, October 23, 2006.
38th Congress of the International Society of Paediatric Oncology, Open Round Table Meeting of the International
Working Group for Teenagers, Adolescents and Young Adults with Cancer, “Education and Health Promotion in
Adolescent and Young Adult Cancer Survivors”, Geneva, Switzerland, September 21, 2006.
Taking on Childhood Cancer, “Transitions After Childhood Cancer”, University of Alabama, Birmingham, Alabama,
November 10, 2006.
Grand Rounds, Memorial Sloan Kettering Cancer Center, “Current Controversies in Therapy for Pediatric Hodgkin
Lymphoma,” New York, January 4, 2007
Miami Pediatric Post-Graduate Course, “Update on Childhood Cancer” and “Special Needs of Childhood Cancer
Survivors, Miami, Florida, March 21, 2007.
National Children’s Cancer Society, Beyond the Cure Teleconference, “Chemotherapy and Radiation Therapy Effects
on Long-Term Health”, May 10, 2007
Chair, Pediatric Cancer II Oral Session, 43rd Annual Meeting American Society of Clinical Oncology, June 3, 2007.
Poster Discussant, 43rd Annual Meeting American Society of Clinical Oncology, June 3, 2007.
Updated 12/07/2010
HUDSON - 26
Methodist Hospital Lunch & Learn, “Providing Care for Survivors of Childhood, Adolescent and Young Adult
Cancers”, Memphis, Tennessee, June 27, 2007.
Cancer Awareness Fair, “Your Turn to Ask the Expert”, Express World Headquarters, Memphis, Tennessee, July 17,
2007.
Second Regional Congress of Cancer & Blood Diseases of Childhood, “Physical and Emotional Impact of
Chemotherapy and Radiotherapy in Pediatric Cancer Survivors” and “Treatment of Refractory/Relapsed Hodgkin
Lymphoma, Amman, Jordan, September 6-8, 2007.
Pediatric Endocrine Society of Texas, Oklahoma, Louisiana, and Arkansas Meeting, “Long-term consequences of
Childhood Cancer”, September 29, 2007.
W.W. Sutow Visiting Lecturer, “Optimizing Health After Childhood Cancer: The Challenges of Translating Research
Findings into Clinical Care”, University of Texas M.D. Anderson Cancer Center, Houston, Texas, October 25, 2007.
39th Congress of the International Society of Paediatric Oncology, Symposium on Transitional Care of Childhood
Cancer Survivors, “Development of Guidelines for Follow Up Care”, Mumbai, India, November 3, 2007.
American Physical Therapy Association Meeting, “Epidemiology, Late Effects, Medical Screening Guidelines, Exercise
Prescription and Health Promotion Among Survivors of Childhood Cancer.” Nashville, Tennessee, February 9, 2008.
St. Jude Domestic Affiliate Social Work Conference, “Late Effects: The Cost of Cure of Pediatric Cancer”, Memphis,
Tennessee, March 14, 2008.
Beyond the Cure, Transitioning of Care After Childhood Cancer Teleconference Series, “Fertility Issues that Impact
Childhood Cancer Survivors”, March 20, 2008.
Scientific Advances in Pediatrics, “Late Effects of Cancer Treatment”, LeBonheur Children’s Medical Center, Memphis,
Tennessee, April 18-19, 2008.
Tennessee Comprehensive Cancer Control Coalition Summit, “Long-term Survivorship Issues”, St. Jude Children’s
Research Hospital, Memphis, TN, May 15-16, 2008.
44th Annual Meeting of the American Society of Clinical Oncology, “Progress & Challenges in Preventing
Cardiovascular Morbidity in Children with Cancer”, Chicago, IL, May 30, 2008.
44th Annual Meeting of the American Society of Clinical Oncology, “Integrating the Humanistic and Scientific Aspects
of Patient Care: The Pediatric Oncologist’s Perspective”, Chicago, IL, June 2, 2008.
UICC World Cancer Congress, “State of the Art on Pediatric Oncology - Long-Term Consequences of Treatment of
Pediatric Malignancies”, Geneva, Switzerland, August 28, 2008.
Grand Rounds, Robert H.Lurie Comprehensive Cancer Center of Northwestern University, “Long-Term Consequences
of Treatment of Pediatric Malignancies”, Chicago, IL, September 5, 2008.
Late Effects Symposium, “Staying Healthy After Childhood Cancer”, Children's Memorial Hospital, Chicago, IL,
September 6, 2008.
Updated 12/07/2010
HUDSON - 27
International Workshop on Pediatric Palliative Care and Care of Long-Term Survivors, “Health Behaviors of Childhood
Cancer Survivors and Strategies for Health Promotion”, “Late Effects After Pediatric Cancer: The Cost of Cure”,
“Facilitating Risk-Based Care of Childhood Cancer Survivors” Servico de Oncologia Pediatrico – IMIP/CEHOPE,
Recife, Brazil, September 10-12, 2008.
Grand Rounds, Nemours Children’s Clinic/A. I. duPont Hospital for Children, “Providing Care for Long-Term
Survivors of Childhood Cancer”, Wilmington, DE, October 1, 2008.
Nemours Children’s Clinic/A. I. duPont Hospital for Children, Late Effects of Childhood Cancer Survivors Conference,
“Optimizing Care After Childhood Cancer”, Wilmington, DE, October 1, 2008.
XXXIInd World Congress of the International Society of Hematology, “Long-Term Effects of Pediatric Oncology
Therapy”, Bangkok, Thailand, October 21, 2008.
Advocate Hope Children’s Hospital, The Post Clinic Pediatric Oncology Survivorship in Transition Conference,
“Staying Healthy After Childhood Cancer”, Chicago, Illinois, October 29, 2008.
St. Jude – Viva Forum in Pediatric Oncology, “Recent advances in the Biology and Treatment of
Hodgkin's Disease”, Singapore, March 4, 2009.
St. Jude Children’s Research Hospital, Challenges in Children’s Health, “Treatment of Long-Term Survivors”,
Memphis, Tennessee, March 28, 2009.
Association of Pediatric Oncology Social Workers 33rd Annual Conference, “Facilitating Health Care Transitions in
Childhood Cancer Survivors” April 24, 2009.
II Congresso Nacional de la Sociedad Espanola de Hematologia y Oncologia Pediatricas, “General Overview of Late
Effects” and “Strategies for Prevention, Intervention and Treatment of Late Effects”, Zaragoza, Spain, May 21-23, 2009.
25th Annual Southwest Virginia Pediatrics Conference, “Providing Care for Long-Term Survivors of Cancer”,
Abingdon, Virginia, August 1-2, 2009.
Chugai Paediatric Hematology Forum, “The St. Jude After Completion of Therapy Program” and “the Children’s
Oncology Group Long-Term Follow-Up Guidelines: Translating Knowledge about Late Effects into Clinical Care”,
Nagoya, Japan, November 6-7, 2009.
University of Texas Southwestern Pediatric Hematology-Oncology Grand Rounds, “Optimizing Health After Childhood
Cancer: The Challenges of Translating Research Findings into Clinical Care”, Dallas, Texas, November 13, 2009.
Color Outside the Lines: Childhood Cancer Survivor Conference, “Staying Healthy After Childhood Cancer”, Dallas,
Texas, November 14, 2009.
Georgetown University Hospital, Department of Obstetrics and Gynecology Grand Rounds, “Reproductive Outcomes
for Survivors of Childhood Cancer”, December 10, 2009.
Second National Dutch Oncology Group LATER Conference on Guidelines and Late Effects Research for Childhood
Cancer Survivors, “Guidelines for Childhood Cancer Survivors in the U.S.A., with a special focus on Hodgkin’s
Lymphoma Survivors”, Erasmus University Medical Center, Rotterdam, The Netherland, March 16, 2010.
23rd Annual Meeting of the American Society of Pediatric Hematology/Oncology, Survivorship Symposium, “Screening
for Medical Late Effects of Childhood Cancer”, Montreal, Quebec, Canada, April 7, 2010.
Danny Thomas Lecture Series, “Optimizing Health in Survivors of Childhood Cancer: The Challenges of Translating
Research Findings into Clinical Care”, St. Jude Children’s Research Hospital, Memphis, Tennessee, April 9, 2010.
Updated 12/07/2010
HUDSON - 28
Chair, American Society of Clinical Oncology Annual Meeting Education Session "Clinical Trials in Survivorship
Populations: Emerging Concepts and Barriers to Application, June 5, 2010.
Discussant, Annual Meeting of the American Society of Clinical Oncology Annual Meeting, Pediatric Oral Abstract
Session, “Cardiac Status in Survivors of Childhood Cancer”, June 7, 2010.
PROFESSIONAL ACTIVITIES
Program Committee, 33rd Annual Meeting of the American Society of Clinical Oncology, Denver, CO, May 17-20,
1997
Program Committee, International Workshop on "Assessing Health-Related Quality of Life in Children with Cancer".
Niagara-on-the-Lake, June 21-24, 1998
Reviewer, NCI Chemoprevention in Genetically-Identified High-Risk Groups: Interactive Research and Development
Projects (RFA: CA-98-012), Rockville, MD, November 4-5, 1998
Member, Children's Oncology Group Hodgkin's Subcommittee on Initial Therapy and Late Effects
Program Committee, Ethical Boundaries in Cancer Genetics Symposium, Memphis, TN, May 26-29, 1999
Reviewer, University of Texas Houston Clinical Research Center Site Visit, Houston, TX, November 30-December 1, 1999
American Society of Clinical Oncology Program/Proceedings Editor Search Committee, 1999.
American Society of Clinical Oncology Publications Committee, 1999-2002
Chair, Childhood Cancer Survivor Study Education Committee, 1999- present.
Member, Childhood Cancer Survivor Study Steering Committee, 1999-present
Vice-chair, Children's Oncology Group Late Effects Committee, 1999-2008
Member, Children’s Oncology Group, Cancer Control Outcomes Subcommittee, 2001-2002
Member, Children’s Oncology Group, Hodgkin’s Disease Committee, 2001-2006
Workshop participant, Centers for Disease Control and Prevention & Lance Armstrong Foundation: Building Partnerships to
Advance Cancer Survivorship and Public Health, June 8-10, 2003
Reviewer, NIH Center for Scientific Review, Pathophysiological Sciences Integrated Review Group, Hepatitis C:
Natural History, Pathogenesis, Therapy and Prevention RO1s, ZRG1 GMA-2 (50), Washington, D.C., July 9-10, 2003.
Co-Chair, Task Force for the Development of the Children’s Oncology Group Childhood Cancer Survivor Long-Term
Follow-Up Guidelines. 2002-present.
Member, National Comprehensive Cancer Network Survivorship Task Force, Chicago, IL, September 30, 2003.
Chair, Scientific Program Committee, Long-Term Follow-Up Guidelines for Childhood Cancer Survivors, 35 th Congress
of the International Society of Paediatric Oncology, Cairo, Egypt, October 8-11, 2003.
Technical Expert, Agency for Healthcare Research and Quality evidence report on “Recruitment of Medically
Underserved Populations to Clinical Trials”, February 2004.
Representative, American Society of Clinical Oncology, for the American College of Radiology Committee on
Appropriateness Criteria, Expert Panel on Radiation Oncology-Hodgkin’s Disease, 2004-2009.
Updated 12/07/2010
HUDSON - 29
Member, External Review Committee, Children’s Cancer Research Fund Proposals, 2004-2006.
Reviewer, Evidence Report “Knowledge and Access to Information on Recruitment of Medically Underserved Populations to
Clinical Trials” prepared by Johns Hopkins Evidence-based Practice Center by the Agency for Healthcare Research and
Quality, November 2004.
Member, American Society of Clinical Oncology Cancer Survivorship Task Force, 2005-2006
Member, Department of Health & Human Services/Federal Drug Administration Pediatric Advisory Committee, 2005-2009
Member, Institute of Medicine Committee on Psychosocial Services to Cancer Patients/Families in a Community Setting,
2006-2007.
American Society of Clinical Oncology Scientific Program Committee, 2006-2008.Reviewer, Canada Foundation for
Innovation New Initiatives Fund proposal, “The Electronic Laboratory for Interdisciplinary Cancer Survivorship
Research: Briding the Gap for Chronic Cancer Care, October 2006.
Member, American Society of Clinical Oncology Survivorship Advisory Group, 2006-2007
Chair, Scientific Program Committee, Scientific Symposium on Transitional Care of Childhood Cancer Survivors, 39 th
Congress of the International Society of Paediatric Oncology, Mumbai, India, October 29-November 3, 2007.
Reviewer, International Committee for the Clinical Research in Cancer (CIR2C), French Ministry of Health for proposal
“Determinants of the Health Status and Quality of Life of Survivors of Childhood Leukemia”, February 22, 2010.
Moderator, Workshop on Adolescent & Young Adult Cancer: Towards Better Outcomes in Canada, Toronto, Canada,
March 11-13, 2010.
Degree Committee, R.D. van Beek thesis on “Endocrine Effects of the Treatment for Acute Lymphoblastic Leukemia
and Hodgkin’s Lymphoma in Childhood”, Erasmus Universiteit Rotterdam, The Netherlands, March 17, 2010.
Reviewer, The Leukemia & Lymphoma Society Translation Research Program 2010 Quality of Life, May 20-21, 2010.
Member, American Association for Cancer Research Survivorship Task Force. May 20, 2010.
Peer Reviewer, Cancer Research United Kingdom Programme Grant Application, August 23, 2010.
Participant, Childhood Cancer Summit Panel Discussion, Improving Quality of Life for Childhood Cancer Survivors,
Washington, D.C., September 16, 2010.
Chair, American Society of Clinical Oncology Cancer Survivorship Committee, 2010-2012
JOURNAL REFEREE:
Pediatric Blood and Cancer
Cancer
Blood
Journal of Clinical Oncology
Journal of Pediatric Hematology Oncology
Medical and Pediatric Oncology
The Oncologist
Journal of Psycho-Oncology
Annals of Oncology
International Journal of Cancer
New England Journal of Medicine
Journal of Cancer Survivorship
Updated 12/07/2010
HUDSON - 30
EDITORIAL BOARDS
Cancer, Pediatric Section Editor, 2000-2010
Journal of Clinical Oncology, Editorial Board, 2001-2004
Journal of Clinical Oncology, Associate Editor, appointment begins 2011
Pediatric Blood and Cancer, 2004-2007
Pediatric Blood and Cancer, Associate Editor, 2007-present
Pediatric HEALTH, 2006-2010
ASCO News & Forum/ASCO Connections, 2005-present
ASCO Cancer.net, Associate Editor, 2010-present
Journal of Cancer Survivorship, 2006-present
Current Cancer Therapy Reviews, 2009
PDQ Pediatric Treatment Editorial Board, 2010
INSTITUTIONAL COMMITTEES:
Previously Held Positions
1990-91
Transfusion and Clinical Labs
1990-98
Institutional Review Board: Vice-Chair, 1997
1991-05
Patient Education Committee, Chair 1999-2005
1991-96
Vice-Chair, Metabolic and Infusion Support Service
1993
Medical Care Guidelines Task Force
1993
St. Jude Hospice Committee
1993-94
Chair, St. Jude Hospice and Home Health Care Guidelines Subcommittee
1994
Physician advisor, Discharge Planning Project Committee
1994-96
LeBonheur CORE Committee on Resident Education
1995
New Hospital Systems Task Force
1995-96
ACU Task Force: SJCRH Information Flow Team
1995
Patient Care Committee
1995-96
Education Program Committee
1996
Clinical Software Selection Team
1996-98
Ad Hoc Committee for Hematology/Oncology Fellowship Training Program
1996-98
Clinical Protocol Scientific Review and Monitoring
1996-99
Faculty Appointments & Promotions Committee
1998-99
St. Jude Library Committee
1998-99
Ad Hoc Task Force Committee on Communication with Referring Physicians.
1998-99
Patient Status Task Force Committee
1999-00
Education Program Committee
1999-00
SJCRH Domestic Affiliate Data Flow Committee
1999-00
Medical Records/Utilization Review
1999-00
Clinical Executive Committee/Medical Executive Committee
1999-01
Cancer Committee
2000-02
Clinical Academic Council
2000-04
MILLI Clinician Advocacy Group
2001-02
Ad Hoc Committee on Scheduling
2001-05
Ambulatory Care Unit Council
2002-04
International Outreach Program Advisory Board
2002-2009
Faculty Appointments & Promotions Committee
2003-05
Cancer Prevention & Control, Scientific Leader Search Committee
2005
Strategic Planning Management Committee
2005
Clinical Research Informatics Advisory Group
2005
St. Jude Endocrinology Needs Task Force
2006-07
Space Planning Committee for Patient Care Arena
2006-07
Chair, Clinical Director/Executive Vice President Advisory Committee
2006-08
Tissue Resource Committee
Updated 12/07/2010
HUDSON - 31
2008-09
2008
2008-09
2008-09
St. Jude Employee Health and Wellness Fair Planning Committee
Search Committee for Chair, Behavioral Medicine
Patient Acceptance Task Force
Search Committee for Director, Nursing Research
Currently Held Positions
1999Cancer Center Leadership Committee
2003Medical Executive Committee
2007Conflict of Interest Committee
2009Patient Care Council
COMPLETED MANUSCRIPTS UNDER REVIEW OR REVISION
1.
Sandlund JT, Hudson MM, Kennedy W, Onciu M, Kastan M. Chemotherapy administration and supportive care
guidelines for children with ataxia-telangiectasia and cancer: a pilot study. Cancer (under review, February 2010)
2.
Kurt BA, Nolan VG, Ness KK, Neglia JP, Tersak JM, Hudson MM, Armstrong GT, Hutchinson RJ, Leisenring
WM, Oeffinger KC, Robison LL, Arora M. Hospitalization rates among survivors of childhood cancer in the
Childhood Cancer Survivor Study cohort. JNCI (under review, July 2010).
3.
Blanco, JG, Sun C-L, Landier W, Chen L, Esparaza-Duran D, Friedman DL, Ginsberg JP, Keller F, Hudson MM,
Neglia JP, Oeffinger K, Ritchey AK, Villaluna D, Relling MV, Bhatia S. Anthracycline-related cardiomyopathy after
childhood cancer: role of polymorphisms in carbonyl-reductase genes – a report from the Children’s Oncology
Group. Lancet (submitted, 11/01/2010).
4.
Krull KR, Annett R, Pan Z, Ness K, Nathan P, Srivastava DK, Jain N, Stovall M, Robison LL, Hudson MM.
Neurocognitive functioning, health behaviors and health care utilization in adult survivors of childhood cancer: a
report from the Childhood Cancer Survivor Study. Psycho-Oncol (submitted, February 2010).
5.
Wampler MA, Galantino ML, Huang S, Gilchrist LS, Marchese VG, Morris GS, Scalzitti D, Hudson MM, Oeffinger
KC, Stovall M, Leisenring WM, Armstrong GT, Robison LL, Ness KK. Factors associated with inactivity in
survivors of lower extremity sarcoma. Medicine and Science in Sports and Exercise (submitted, March 2010).
6.
Huang T-T, Hudson MM, Stokes DC, Krasin MJ, Spunt SL, Ness KK. Pulmonary outcomes in survivors of
childhood cancer: a systematic review. Chest (revise/resubmit, 11/2010).
7.
Kahalley LS, Conklin HM, Tyc VL, Wilson S, Hinds PS, W S, Xiaoping X, Hudson MM. ADHD and secondary
ADHD criteria fail to identify many at-risk survivors of pediatric ALL and brain tumor. Pediatr Blood Cancer
(revise/resubmit, 11/2010).
Updated 12/07/2010
Download
Related flashcards

Oncology

38 cards

Cancer organizations

24 cards

Cancer hospitals

29 cards

American oncologists

54 cards

Create Flashcards